Disease by etiologic mechanism
MONDO:7770008A grouping class for human diseases classified by their etiologic mechanism, encompassing primarily intrinsic (genetic, genomic), primarily extrinsic (e.g., infections, toxins, radiation), and complex multifactorial (e.g. nutritional) causes.
52053 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsSub-types
Broader categories
Showing the 400 most recently updated of 12276 trials in this tab.
-
Could a vaccine given during pregnancy shield infants from a deadly virus?
⭐️ VACCINE ⭐️ CompletedThis study tests an RSV vaccine in pregnant women living with HIV. The goal is to see if the vaccine is safe and helps mothers pass protective antibodies to their babies, potentially preventing severe RSV lung infections in infants. The trial involves about 681 pregnant participa…
Phase: PHASE3 • Sponsor: Pfizer • Aim: ⭐️ VACCINE ⭐️
Last updated Jul 04, 2026 00:00 UTC
-
Could one HPV shot be enough for kids with HIV? new study investigates
⭐️ VACCINE ⭐️ CompletedThis study looks at children and teens with HIV to find the best number of HPV vaccine doses. Researchers are comparing one, two, or three doses to see if fewer shots can still provide strong protection against HPV. The goal is to simplify vaccination and improve health outcomes …
Phase: PHASE4 • Sponsor: Fred Hutchinson Cancer Center • Aim: ⭐️ VACCINE ⭐️
Last updated Jul 04, 2026 00:00 UTC
-
Could a Lower-Dose polio vaccine help eradicate the disease?
⭐️ VACCINE ⭐️ CompletedThis study tests a hexavalent vaccine that protects against six diseases, including polio, but uses a lower dose of the inactivated polio vaccine (IPV). The goal is to see if this reduced-dose version works as well as the standard full-dose vaccine in infants. Around 1,500 health…
Phase: PHASE3 • Sponsor: Serum Institute of India Pvt. Ltd. • Aim: ⭐️ VACCINE ⭐️
Last updated Jul 03, 2026 00:00 UTC
-
New adjuvanted flu vaccine aims to boost protection in older adults
⭐️ VACCINE ⭐️ CompletedThis phase 2b trial tests several versions of an experimental flu vaccine that includes an adjuvant (MF59) to strengthen the immune response. The vaccine is made from cells, not eggs, and targets four flu strains. Around 1,000 adults aged 50 and older receive a single shot and ar…
Phase: PHASE2 • Sponsor: Seqirus • Aim: ⭐️ VACCINE ⭐️
Last updated Jul 02, 2026 00:00 UTC
-
New oral vaccine aims to shield infants from severe rotavirus
⭐️ VACCINE ⭐️ CompletedThis phase 3 study tests whether three doses of an oral rotavirus vaccine (ROTAVAC 5D) can prevent severe diarrhea in healthy infants. Around 4,270 Chilean babies receive either the vaccine or a placebo. Researchers track cases of severe rotavirus gastroenteritis to measure the v…
Phase: PHASE3 • Sponsor: University of Chile • Aim: ⭐️ VACCINE ⭐️
Last updated Jul 02, 2026 00:00 UTC
-
New Freeze-Dried rabies vaccine aims to save lives in High-Risk regions
⭐️ VACCINE ⭐️ CompletedThis phase 3 trial tests a freeze-dried rabies vaccine in healthy Chinese volunteers aged 10 to 60. The study compares the new vaccine's ability to trigger protective antibodies and its safety against an existing rabies vaccine. Rabies is nearly always fatal once symptoms appear,…
Phase: PHASE3 • Sponsor: Jiangsu Province Centers for Disease Control and Prevention • Aim: ⭐️ VACCINE ⭐️
Last updated Jul 01, 2026 00:00 UTC
-
New vaccine aims to protect infants from deadly diarrhea
⭐️ VACCINE ⭐️ CompletedThis study tests a new vaccine called Shigella4V, designed to protect against shigellosis, a severe diarrheal disease. Researchers are giving the vaccine to healthy adults, children, and 9-month-old infants to check its safety and whether it triggers a strong immune response. Dif…
Phase: PHASE1, PHASE2 • Sponsor: LimmaTech Biologics AG • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 14:03 UTC
-
Cancer drug Imatinib's Long-Term safety tracked in ongoing patients
Disease control CompletedThis study looks at the long-term safety of imatinib, a daily pill for certain cancers like GIST and CML. It includes 250 patients who were already benefiting from imatinib in a previous Novartis trial and continue taking it. The main goal is to track side effects over time, with…
Phase: PHASE4 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Hormone shot timing may affect recovery after prostate cancer treatment
Disease control CompletedThis trial compares two types of hormone injections given before prostate brachytherapy (internal radiation) for early-stage prostate cancer. One injection lasts one month, the other three months, and both are used to lower testosterone to make radiation more effective. The study…
Phase: NA • Sponsor: University of British Columbia • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Could drug holidays improve thyroid cancer treatment?
Disease control CompletedThis study compares two ways of taking the drug pazopanib for people with advanced differentiated thyroid cancer that no longer responds to radioactive iodine. One group takes pazopanib continuously, while the other takes planned breaks and restarts the drug only if the cancer pr…
Phase: PHASE2 • Sponsor: Centre Leon Berard • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
AI-Powered navigation aims to pinpoint tiny lung nodules during surgery
Disease control CompletedThis study tests a device called the LungVision system, which uses artificial intelligence to help surgeons locate small lung nodules during minimally invasive surgery. The system combines CT scans with live X-ray images to guide a tool to the nodule, then injects a dye to mark i…
Phase: NA • Sponsor: Tri-Service General Hospital (TSGH) • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Temporary bypass device aims to protect surgical connections in colorectal cancer
Disease control CompletedThis trial tests a temporary device called CG-100 that is placed inside the intestine during colorectal cancer surgery. The device is designed to protect the surgical connection while it heals, potentially reducing leaks and other complications. The study includes adults aged 22 …
Phase: NA • Sponsor: Colospan Ltd. • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
New combo aims to extend life in stomach cancer
Disease control CompletedThis study tests whether a combination of ramucirumab plus FOLFIRI (a standard chemo regimen) works better than ramucirumab plus paclitaxel for people with advanced stomach or gastroesophageal junction cancer that has worsened after one prior chemo treatment. About 429 participan…
Phase: PHASE2, PHASE3 • Sponsor: Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Immune cells supercharged to fight cancer: early trial shows promise
Disease control CompletedThis early-phase trial tested whether giving patients their own natural killer (NK) cells, boosted by the drug bortezomib, is safe for treating advanced cancers like leukemia, lung, and pancreatic cancer. Thirty-five adults whose cancers had not responded to standard treatments r…
Phase: PHASE1 • Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Weekly shot aims to get severe hemophilia patients moving more
Disease control CompletedThis study is testing a new medicine called efanesoctocog alfa in about 90 people aged 12 and older with severe hemophilia A. Participants receive a weekly injection for 24 months to see if it helps them be more physically active and improves joint health. The study uses activity…
Phase: PHASE3 • Sponsor: Swedish Orphan Biovitrum • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Engineered immune cells aim to trick the body into accepting a new kidney
Disease control CompletedThis trial tests a new cell therapy called TX200-TR101 in people who receive a kidney from a living donor. The therapy is made from the patient's own immune cells, which are genetically modified to help the body accept the donated kidney instead of rejecting it. The study focuses…
Phase: PHASE1, PHASE2 • Sponsor: Sangamo Therapeutics • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
New eye drug shows promise for blinding disease
Disease control CompletedThis early-stage trial tests an experimental drug called Kamuvudine-8 (K8) for people with geographic atrophy, a form of advanced age-related macular degeneration that causes vision loss. About 30 participants receive eye injections of K8 and are monitored for 26 weeks to check s…
Phase: PHASE1, PHASE2 • Sponsor: Michelle Abou-Jaoude • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
New hope for young hemophilia patients: jivi safety trial shows promise for fewer injections
Disease control CompletedThis study tested the safety of Jivi (BAY 94-9027), a longer-lasting clotting factor, in 36 children aged 7 to 12 with severe hemophilia A. The medicine is already approved for older patients, but this trial focused on younger kids to check for allergic reactions and whether the …
Phase: PHASE3 • Sponsor: Bayer • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
New epilepsy drug candidate aims to tame severe seizures
Disease control CompletedThis study tests whether cenobamate, an experimental anti-epileptic drug, can safely reduce primary generalized tonic-clonic (PGTC) seizures when added to a person's usual seizure medications. Adults and adolescents aged 12 and older with PGTC seizures are randomly assigned to re…
Phase: PHASE3 • Sponsor: SK Life Science, Inc. • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Experimental gene therapy targets rare nerve disease
Disease control CompletedThis study tested a gene transfer treatment for giant axonal neuropathy (GAN), a rare genetic disease that damages nerves and affects movement, breathing, and other functions. Fourteen people aged 3 and older received a single injection of the treatment into the fluid around the …
Phase: PHASE1 • Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Brain gene therapy tested for Parkinson's
Disease control CompletedThis early-phase study tested a gene therapy that delivers a protective protein (GDNF) directly to the brain in 25 people with advanced Parkinson's disease. The goal was to see if it is safe and to gather early information on whether it might help protect dopamine-producing brain…
Phase: PHASE1 • Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Triple threat before surgery: could a new combo wipe out stomach cancer cells?
Disease control CompletedThis study tests whether giving a three-part treatment before surgery can improve outcomes for people with locally advanced stomach or gastroesophageal junction cancer. The treatment combines an immunotherapy drug (tislelizumab) with standard chemotherapy and a short course of ra…
Phase: PHASE2 • Sponsor: Jiangsu Cancer Institute & Hospital • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
New combo approach tackles teen obesity: counseling plus pills
Disease control CompletedThis study tests whether combining lifestyle counseling with weight-loss medication helps teens aged 12–17 with severe obesity lose weight. About 120 participants will receive counseling and medication for a year. The goal is to find a practical, effective treatment that is easie…
Phase: PHASE2 • Sponsor: University of Minnesota • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Combination therapy targets resistant breast cancer
Disease control CompletedThis trial investigates whether adding everolimus (RAD001) to trastuzumab (Herceptin) can help people with a specific type of advanced breast cancer that has stopped responding to trastuzumab alone. The study includes people with HER2-positive, PTEN-deficient metastatic breast ca…
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
New drug combo aims to boost cancer treatment
Disease control CompletedThis early-phase trial tested whether adding nilotinib (a pill) to paclitaxel (a chemotherapy) is safe and tolerable for people with advanced solid tumors that no longer respond to standard treatments. The study included 47 adults and children aged 12 and older. Researchers aimed…
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Smartwatch-Guided exercise may tame pregnancy risks
Disease control CompletedThis study investigates whether a structured, personalized exercise plan—tracked with a smartwatch and supported by regular phone check-ins—can help control blood sugar, blood pressure, and weight gain in pregnant women with gestational diabetes, chronic hypertension, or obesity.…
Phase: NA • Sponsor: Unidade Local de Saúde de Coimbra, EPE • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Can extra tdap shots boost Life-Saving plasma?
Disease control CompletedThis study looks at whether giving the Tdap vaccine every 3 months for a year is safe for healthy plasma donors. Normally, this vaccine is given once every 10 years. The goal is to see if more frequent vaccination produces high levels of tetanus antibodies in the plasma, which co…
Phase: PHASE2 • Sponsor: ABO Holdings, Inc. • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Could a daily dose of fiber from thai jerusalem artichoke reshape gut bacteria and trim body fat in obese kids?
Disease control CompletedThis study investigates whether a daily fiber supplement called inulin, extracted from Thai Jerusalem artichoke, can change the gut bacteria and reduce body fat in obese children aged 7 to 15. Over six months, one group receives inulin, another gets a placebo, and a third group r…
Phase: NA • Sponsor: Chulalongkorn University • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Can a smartphone-guided exercise program help people with Parkinson's walk better and stay active?
Disease control CompletedThis study tests whether a 10-week home exercise program, delivered through eHealth technology, can improve walking, physical activity, and quality of life in people with mild-to-moderate Parkinson's disease. The program combines motor and cognitive exercises tailored to each per…
Phase: NA • Sponsor: Stiftelsen Stockholms Sjukhem • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Could an ancient herb keep breast cancer at bay?
Disease control CompletedThis study follows 66 women with stage II/III breast cancer who received a natural supplement called PG2 (from astragalus root) alongside their standard chemotherapy. Researchers want to see if PG2 helps delay cancer recurrence or spread, and whether it improves survival. The goa…
Sponsor: Kun-Ming Rau • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Can a website help cancer survivors live healthier? large study tests online lifestyle coaching
Disease control CompletedThis study tests whether a secure website with educational sessions, goal-setting, and tracking tools can help survivors of several cancers (including breast, prostate, colorectal, and others) improve their diet, increase physical activity, and manage weight. Participants are age…
Phase: NA • Sponsor: University of Alabama at Birmingham • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
New radiation approach aims to tame prostate cancer with fewer side effects
Disease control CompletedThis study tests a type of radiation called high-dose brachytherapy for men with prostate cancer that hasn't spread. Doctors place tiny radioactive sources directly into the prostate to deliver a strong dose to the tumor while sparing nearby healthy tissue. The goal is to control…
Phase: NA • Sponsor: Stanford University • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Double-Drug attack on tough lung cancer mutation
Disease control CompletedThis study tests whether combining two targeted drugs, avutometinib and adagrasib, can shrink tumors in people with advanced non-small cell lung cancer that has a specific genetic change called KRAS G12C. Participants must have already tried a KRAS G12C inhibitor and seen their c…
Phase: PHASE1, PHASE2 • Sponsor: Verastem, Inc. • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Smartphone app aims to help black smokers with HIV kick the habit
Disease control CompletedThis study tests a mobile app designed specifically for Black adults living with HIV who smoke daily. The app includes culturally tailored content and anxiety-reduction techniques to support quitting. Participants are randomly assigned to use either the tailored app or a standard…
Phase: NA • Sponsor: University of Houston • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Two-Drug immunotherapy combo shows promise for advanced kidney cancer
Disease control CompletedThis study tested a combination of two immunotherapy drugs—high-dose interleukin-2 (IL-2) and pembrolizumab (Keytruda)—in 27 adults with metastatic kidney cancer. The goal was to see if the combination could shrink or eliminate tumors. Participants received both drugs in a coordi…
Phase: PHASE2 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
New pill aims to prevent fat spike after Weight-Loss drug stop
Disease control CompletedThis study tested whether the drug RDX-002 can lower high blood fat levels in people who recently stopped taking weight-loss medications like semaglutide or tirzepatide. Sixty-eight adults who had lost at least 10% of their body weight on those drugs took either RDX-002 or a plac…
Phase: PHASE2 • Sponsor: Response Pharmaceuticals • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Drug that starves tumors shows promise against advanced kidney cancer
Disease control CompletedThis phase II trial tests the drug lenalidomide (CC-5013) in people with advanced or inoperable kidney cancer. Lenalidomide works by cutting off blood flow to tumors, which may stop or slow their growth. The study aims to see how many patients respond to treatment and what side e…
Phase: PHASE2 • Sponsor: The Cleveland Clinic • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Engineered donor cells take aim at returning blood cancers
Disease control CompletedThis early-phase study tested a new approach for people whose B-cell cancers (like lymphoma or leukemia) came back after a donor stem cell transplant. Researchers took white blood cells from the original donor, genetically modified them to recognize and attack cancer cells, and g…
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Sleep more, slash diabetes risk? small study tests the idea.
Disease control CompletedThis study looked at whether getting more sleep or keeping a regular bedtime could improve how the body handles sugar and insulin in overweight adults who usually sleep less than 7 hours a night. Eighteen African American men and women aged 21-50 were asked to either extend their…
Phase: NA • Sponsor: University of Chicago • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
New oral drug HRS-9813 takes first step against scarred lungs
Disease control CompletedThis Phase 1 trial tests the safety and how the body handles HRS-9813, an experimental oral drug for idiopathic pulmonary fibrosis (a lung-scarring disease). Healthy volunteers aged 18-45 take multiple doses to measure side effects and drug levels in the blood. The study does not…
Phase: PHASE1 • Sponsor: Guangdong Hengrui Pharmaceutical Co., Ltd • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Experimental drug hopes to boost chemo against tough pancreatic cancer
Disease control CompletedThis trial investigates whether adding antroquinonol (Hocena) to standard chemotherapy (nab-paclitaxel and gemcitabine) can safely treat people with metastatic pancreatic cancer that has not yet been treated. The study has two phases: first, finding the best dose, and second, che…
Phase: PHASE1, PHASE2 • Sponsor: Golden Biotechnology Corporation • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Weekly shot may boost growth in kids with dwarfism
Disease control CompletedThis study tests a weekly injection called TransCon CNP in children aged 2 to 10 with achondroplasia, the most common form of dwarfism. The goal is to see if it can safely improve growth over one year. Half the children receive the drug and half receive a placebo, and all childre…
Phase: PHASE2 • Sponsor: Ascendis Pharma A/S • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Bee product may boost health in oral cancer survivors
Disease control CompletedThis study tests whether a daily dose of Taiwanese Green Propolis, a natural bee-derived supplement, can improve blood fat levels, reduce fatigue, and enhance quality of life in people who have completed treatment for oral cavity cancer. Participants take either propolis capsules…
Phase: NA • Sponsor: Taipei Medical University • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
New drug duo aims to shrink advanced kidney tumors
Disease control CompletedThis phase 2 trial is testing a new drug called cadonilimab (AK104), either alone or combined with axitinib, as a first treatment for advanced or metastatic kidney cancer. The study includes two parts: one testing different doses of cadonilimab alone in various kidney cancer type…
Phase: PHASE2 • Sponsor: Akeso • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
New drug combo shows promise for Hard-to-Treat cancers
Disease control CompletedThis study tests an experimental drug called XmAb24306, given alone or with another cancer drug (atezolizumab), in people with advanced solid tumors that cannot be cured. The main goal is to check the drug's safety and how the body processes it. About 195 participants will take p…
Phase: PHASE1 • Sponsor: Genentech, Inc. • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Experimental cell therapy takes aim at Hard-to-Treat cancers
Disease control CompletedThis early-stage trial tests an experimental cell therapy called IBR854 in people with advanced solid tumors that cannot be surgically removed or have spread. The main goals are to check the treatment's safety and find the right dose. Participants receive the cells by infusion tw…
Phase: PHASE1 • Sponsor: Imbioray (Hangzhou) Biomedicine Co., Ltd. • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Which exercise helps teens recover best from scoliosis surgery?
Disease control CompletedThis study compares different exercise programs for adolescents with idiopathic scoliosis who have undergone spinal fusion surgery. Participants are divided into three groups: one doing body awareness therapy plus core stabilization, one doing core stabilization alone, and a cont…
Phase: NA • Sponsor: NURSİMA İNCE • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
New combo therapy shows promise for Hard-to-Treat breast cancer
Disease control CompletedThis early-phase study tested a combination of two drugs—capecitabine (a chemotherapy pill) and cemiplimab (an immunotherapy)—in 13 people with hormone receptor-positive breast cancer that had spread. The main goal was to find the safest dose and see if the combo could shrink tum…
Phase: PHASE1 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
CF breakthrough: kids may ditch daily enzyme pills after modulator treatment
Disease control CompletedThis study looked at whether children with cystic fibrosis (CF) who are taking CFTR modulator drugs and have regained normal pancreatic function can safely stop taking pancreatic enzyme replacement therapy (PERT). Seventeen children were followed for six months after stopping enz…
Phase: PHASE4 • Sponsor: Indiana University • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Could a chatty flowerpot robot reduce caregiver dependence?
Disease control CompletedThis study tests whether a small social robot named Tessa can help people with disabilities who have trouble planning and remembering daily tasks. Participants use the robot in their home, and researchers track how much professional caregiver support they need. The goal is to see…
Phase: NA • Sponsor: Academy Het Dorp • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Immunotherapy drug keytruda takes on mysterious cancers of unknown origin
Disease control CompletedThis phase 2 trial is investigating whether the immunotherapy drug pembrolizumab (Keytruda) can help people with a rare and aggressive cancer called carcinoma of unknown primary (CUP), where doctors cannot find where the cancer started. Participants have not received prior treatm…
Phase: PHASE2 • Sponsor: AHS Cancer Control Alberta • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Could a Two-Drug punch wipe out melanoma before surgery?
Disease control CompletedThis phase 2 pilot study tests whether adding the investigational drug vidutolimod to the immunotherapy nivolumab can destroy more melanoma tumors in lymph nodes or nearby skin areas before surgery. Participants have stage IIIB/C/D melanoma that has spread but not to distant orga…
Phase: PHASE2 • Sponsor: Diwakar Davar • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
New pill targets Hard-to-Treat lymphoma in early human test
Disease control CompletedThis early-stage trial tests an experimental oral drug called DZD8586 in adults with B-cell Non-Hodgkin lymphoma that has returned or stopped responding to standard treatments. The study aims to find a safe dose and check whether the drug can shrink tumors. Participants take the …
Phase: PHASE1 • Sponsor: Dizal Pharmaceuticals • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Could a smartphone replace the nurse? study tests video monitoring for TB treatment
Disease control CompletedThis study compares two ways of making sure people with tuberculosis (TB) take their medicine correctly: traditional in-person observation by a healthcare worker versus electronic observation using live video or recorded videos on a computer or phone. The trial involves 216 TB pa…
Phase: NA • Sponsor: Centers for Disease Control and Prevention • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Which radiotherapy technique offers best value for pelvic cancers?
Disease control CompletedThis trial compares three modern radiotherapy techniques—helical tomotherapy and two types of dynamic arc therapy (RapidArc and VMAT)—for treating prostate, cervical, and anal canal cancers that require pelvic lymph node irradiation. The goal is to determine which method is most …
Phase: NA • Sponsor: Institut Cancerologie de l'Ouest • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
New program aims to keep patients on track after Infection-Related hospitalizations
Disease control CompletedThis study tested a program to help people with opioid use disorder stay on their medication after being hospitalized for serious infections like endocarditis or bone infections. Forty adults took part to see if the program was practical and helpful. The goal is to improve long-t…
Phase: NA • Sponsor: Boston Medical Center • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Laser precision could transform oral cancer prevention surgery
Disease control CompletedThis trial compares two surgical methods for removing oral epithelial dysplasia, a precancerous condition of the mouth lining. One group receives laser surgery, while the other has traditional scalpel removal. Researchers measure wound healing speed, swelling, redness, and pain t…
Phase: NA • Sponsor: I.M. Sechenov First Moscow State Medical University • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Could a natural compound in food help aging hearts?
Disease control CompletedThis study tests whether spermidine, a natural substance found in foods like soy and aged cheese, can improve heart and muscle health in elderly people with coronary artery disease. 180 participants aged 65 and older will receive either spermidine capsules or a placebo for a peri…
Phase: PHASE2 • Sponsor: University of Aarhus • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Shorter wait for light therapy? study tests faster treatment for Sun-Damaged skin
Disease control CompletedThis study compares two different incubation times for a light-activated cream used to treat actinic keratosis, a common precancerous skin condition caused by sun exposure. Participants receive either no wait or a one-hour wait after applying the cream before blue light therapy. …
Phase: NA • Sponsor: Northwestern University • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
New cocktail aims to make immunotherapy work for common colorectal cancer
Disease control CompletedThis phase 2 trial is testing whether a combination of chemotherapy (mFOLFOX6), a targeted therapy (bevacizumab), and an immunotherapy (PD-1 inhibitor) can help people with a specific type of locally advanced colorectal cancer called microsatellite stable (MSS). Unlike other colo…
Phase: PHASE2 • Sponsor: Sixth Affiliated Hospital, Sun Yat-sen University • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Could a blood clot replace root canal fillings? new study tests regenerative approach
Disease control CompletedThis study tests whether leaving a tooth's root canal unfilled and using a blood clot to trigger natural healing works as well as the standard root canal filling. The trial involves 48 men with infected but still living upper premolars. One group gets the standard gutta-percha fi…
Phase: NA • Sponsor: Ain Shams University • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Can a higher dose of ustekinumab rescue Crohn's patients who lost response?
Disease control CompletedThis study looked at 108 adults with Crohn's disease whose symptoms returned while on standard ustekinumab treatment. Researchers gave them a re-induction infusion and then split them into two groups: one continued the usual shot every 8 weeks, the other got a shot every 4 weeks.…
Phase: PHASE3 • Sponsor: Belgian Inflammatory Bowel Disease Research and Development (BIRD) VZW • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
New chemo cocktail targets Hard-to-Treat testicular cancer
Disease control CompletedThis study tests a combination of three chemotherapy drugs—gemcitabine, oxaliplatin, and paclitaxel—in people with advanced testicular cancer that has not responded to standard cisplatin-based treatment or has returned after treatment. The goal is to see if this drug combination …
Phase: PHASE2 • Sponsor: University of Southern California • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Could a simple supplement protect HIV-Exposed babies from infections?
Disease control CompletedThis study tests whether a synbiotic supplement (a mix of a prebiotic called 2'-FL HMO and a probiotic called B. infantis) can reduce infections and improve growth in infants who were exposed to HIV but are not infected themselves. About 140 infants will receive either the supple…
Phase: NA • Sponsor: Columbia University • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
New cocktail of drugs aims to tackle tough lung cancer
Disease control CompletedThis phase 2 trial tests whether adding experimental drugs (MK-4830, boserolimab, or lenvatinib) to the standard combination of pembrolizumab and chemotherapy can improve outcomes for people with extensive-stage small cell lung cancer. Participants receive one of these new combin…
Phase: PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
New counseling approach helps zambians with HIV cut alcohol and boost viral control
Disease control CompletedThis study tested whether brief or in-depth counseling could help people living with HIV in Zambia reduce unhealthy alcohol use and improve HIV treatment. 680 adults who were on HIV medication and had hazardous drinking plus mental health or substance use issues took part. Partic…
Phase: NA • Sponsor: University of Alabama at Birmingham • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
New drug duo shows promise against tough cancers
Disease control CompletedThis study tested whether two drugs, zanidatamab and evorpacept, are safe and can shrink tumors in people with advanced HER2-expressing cancers. Fifty-two patients with breast or other cancers that had spread or couldn't be removed by surgery took part. The goal was to see how ma…
Phase: PHASE1, PHASE2 • Sponsor: Jazz Pharmaceuticals • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Experimental fetal fluid therapy aims to save babies born without kidneys
Disease control CompletedThis trial tests whether repeatedly adding sterile fluid into the womb can help fetuses with severe kidney failure grow enough lungs to survive after birth. Pregnant women with early pregnancy kidney failure can choose to receive the infusions or just be monitored. Babies who sur…
Phase: PHASE1 • Sponsor: Johns Hopkins University • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Virtual reality could make scoliosis exercises more effective for teens
Disease control CompletedThis study compares standard Schroth exercises with a virtual reality version of the same exercises in teens aged 10–15 with mild adolescent idiopathic scoliosis (curves of 10–30 degrees). The goal is to see if adding VR improves spinal alignment, trunk rotation, and mobility mor…
Phase: NA • Sponsor: Istanbul University - Cerrahpasa • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Double-Barreled chemo attack on bile duct cancer shows promise
Disease control CompletedThis study tests a two-pronged chemotherapy approach for people with intrahepatic cholangiocarcinoma (a type of bile duct cancer) that cannot be removed by surgery. Participants receive chemotherapy directly to the liver through a surgically placed pump, plus standard chemotherap…
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
New drug AZD9829 targets hard-to-treat blood cancers in early trial
Disease control CompletedThis study tests a new drug, AZD9829, in people with blood cancers that have come back or not responded to other treatments. The drug targets a protein called CD123 found on cancer cells. The main goals are to find a safe dose and check for side effects. About 56 adults will take…
Phase: PHASE1, PHASE2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
New drug combo shows promise for Hard-to-Treat breast cancer
Disease control CompletedThis phase 2 trial tests a new drug called TVB-2640 (denifanstat) combined with trastuzumab and either chemotherapy (paclitaxel) or hormone therapy in 17 people with HER2+ metastatic breast cancer that no longer responds to trastuzumab. TVB-2640 blocks an enzyme cancer cells need…
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Could a common ADHD drug help kids with severe obesity?
Disease control CompletedThis study tests whether the drug lisdexamfetamine (Vyvanse), usually used for ADHD, can help children aged 6 to 12 with severe obesity lose weight. About 44 children will receive either the drug or a placebo, plus lifestyle therapy, for 24 weeks. The main goal is to see if their…
Phase: EARLY_PHASE1 • Sponsor: University of Minnesota • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
New pill aims to slow vision loss in rare usher syndrome
Disease control CompletedThis study tests whether NPI-001 tablets can safely slow or stop vision loss in people with Usher syndrome, a rare genetic condition that causes blindness and hearing loss. About 49 adults will take either the study drug or a placebo for 24 months. The main goal is to see if the …
Phase: PHASE1, PHASE2 • Sponsor: Nacuity Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
New pill takes aim at Hard-to-Treat cancers
Disease control CompletedThis early-phase trial tests an experimental tablet called YZJ-5053 in people with advanced solid tumors who have no standard treatment options left. The main goals are to find a safe dose and check for side effects. Researchers will also look at how the drug moves through the bo…
Phase: PHASE1 • Sponsor: Shanghai Haiyan Pharmaceutical Technology Co., Ltd. • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Lighter suction after lung surgery may speed recovery
Disease control CompletedThis trial tests whether a gentler suction level (-2 cmH2O) on chest tubes after keyhole lung cancer surgery works as well as the standard stronger suction (-10 cmH2O). The goal is to see which setting allows tubes to be removed sooner and causes fewer complications. About 230 ad…
Phase: NA • Sponsor: Rigshospitalet, Denmark • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Simple breathing moves may help young children fight pneumonia
Disease control CompletedThis study tests whether special breathing techniques called neurophysiological facilitation of respiration can improve oxygen levels and shorten hospital stays in children aged 6 months to 2 years with pneumonia. The techniques involve gentle stretches and co-contraction of the …
Phase: NA • Sponsor: Asmaa Ahmed Abd El-samad • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
DNA vaccine trains immune system to fight brain cancer
Disease control CompletedThis early-stage trial tests a DNA vaccine called ITI-1001 in people with newly diagnosed glioblastoma, an aggressive brain cancer. The vaccine is designed to teach the immune system to recognize and attack cancer cells that carry common cytomegalovirus (CMV) proteins. About 10 p…
Phase: PHASE1 • Sponsor: Immunomic Therapeutics, Inc. • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Could a Two-Vaccine strategy better shield spleenless patients from pneumonia?
Disease control CompletedThis trial investigates whether giving two different pneumonia vaccines—one followed by another a year later—boosts immune protection more than a single vaccine alone in adults who have had their spleen removed. People without a spleen are at higher risk for serious pneumococcal …
Phase: PHASE2 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Could Man's best friend help teens get fit? new study tests a Dog-Inspired health program
Disease control CompletedThis study tests whether adding a canine health-literacy module to an existing family lifestyle program helps overweight teens and their parents become more active. The program includes lessons on dog care, behavior, and exercise, along with activity trackers and surveys. Partici…
Phase: NA • Sponsor: Children's Hospital Los Angeles • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Supercharged immune cells take on Hard-to-Treat myeloma
Disease control CompletedThis early-phase study tests a new treatment for multiple myeloma that has returned or stopped responding to prior therapies. It combines specially engineered natural killer (NK) cells (called TiNK) with an antibody drug (isatuximab) and standard chemotherapy. The main goal is to…
Phase: PHASE1 • Sponsor: Elvira Umyarova • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
New oral drug EP395 tested for COPD safety
Disease control CompletedThis phase 2 trial investigates the safety and tolerability of EP395, an oral capsule taken once daily for 12 weeks, in people with chronic obstructive pulmonary disease (COPD). The study includes 61 adults aged 45 and older and compares EP395 against a placebo. Researchers monit…
Phase: PHASE2 • Sponsor: EpiEndo Pharmaceuticals • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
New drug shrinks tumors in patients with rare gene mutation
Disease control CompletedThis study tested the drug larotrectinib in 215 adults with various solid cancers that have a specific change in the NTRK gene. The drug is taken orally and works by blocking the action of the altered gene. The main goal was to see how many patients had their tumors shrink or dis…
Phase: PHASE2 • Sponsor: Bayer • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
New strategy aims to cut unnecessary antibiotics in pneumonia care
Disease control CompletedThis study tests two approaches to reduce the overuse of broad-spectrum antibiotics in adults hospitalized with community-acquired pneumonia. Researchers will compare rapid diagnostic testing and pharmacist-led de-escalation, alone or together, against usual care. The goal is to …
Phase: NA • Sponsor: The Cleveland Clinic • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Fat stem cells infused into kidney artery to fight transplant rejection
Disease control CompletedThis early-stage trial tests whether a single infusion of stem cells from donated fat tissue can safely treat rejection in kidney transplant recipients. The cells are delivered directly into the kidney artery. The study includes 12 adults with biopsy-proven rejection and aims to …
Phase: PHASE1 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Promising combo tackles tough cancers in early trial
Disease control CompletedThis early-phase study tested the safety of combining two drugs—pembrolizumab (an immunotherapy) and AMG386 (which targets blood vessel growth)—in 62 people with advanced solid tumors like melanoma, ovarian, renal, or colorectal cancer. The main goals were to find the safest dose…
Phase: PHASE1 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Vitamin d derivative may help keep bones strong after menopause
Disease control CompletedThis trial investigates whether doxercalciferol, a form of vitamin D, can prevent bone loss in the spine and thigh bone in postmenopausal women with low bone density. Participants take either doxercalciferol or a placebo daily for two years, with bone density measured at the star…
Phase: PHASE2, PHASE3 • Sponsor: Creighton University • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Fat freezing may cool inflammation in Menopause-Related obesity
Disease control CompletedThis study investigates whether cryolipolysis, a non-invasive fat freezing technique, can lower inflammatory markers in obese postmenopausal women. Participants are women aged 50-60 with a BMI of 30-40. The treatment is applied to the lower belly for 30 minutes, and researchers m…
Phase: NA • Sponsor: Cairo University • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Could a vitamin cocktail fix energy problems in autism?
Disease control CompletedThis study tests whether a wide-spectrum nutritional supplement can improve mitochondrial function in children with autism spectrum disorder (ASD). Mitochondria are the energy factories in cells, and some children with ASD have abnormal mitochondrial activity. The trial enrolls c…
Phase: PHASE2 • Sponsor: Rossignol Medical Center • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Telehealth program aims to get HIV treatment to people who inject drugs faster
Disease control CompletedThis study tested two ways to offer HIV treatment, hepatitis C treatment, and substance use disorder medications to people who inject drugs. One group received a telehealth-enhanced program with on-demand services like mobile blood draws and counseling, while the other group got …
Phase: NA • Sponsor: University of Miami • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
New pill aims to tackle obesity and diabetes by calming inflammation
Disease control CompletedThis study tests an experimental drug called NT-0796 in 176 obese adults, some with type 2 diabetes. Participants take the drug or a placebo alongside a reduced-calorie diet and increased physical activity for 6 months. The goal is to see if the drug helps with weight loss and re…
Phase: PHASE2 • Sponsor: NodThera Limited • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Could low-dose radiation boost cancer treatment before surgery?
Disease control CompletedThis study compares two treatment approaches for people with operable head and neck squamous cell carcinoma. One group receives low-dose radiotherapy plus targeted therapy and immunotherapy before surgery, while the other gets only targeted therapy and immunotherapy. The goal is …
Phase: PHASE2 • Sponsor: West China Hospital • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
New drug cuts chemotherapy side effect by over 60% in breast cancer patients
Disease control CompletedThis study tested whether Naderin, an immune-boosting drug, could prevent low white blood cell counts in 79 women with breast cancer receiving first-line chemotherapy. Participants either received Naderin alongside chemotherapy or chemotherapy alone. The results showed that only …
Phase: PHASE2, PHASE3 • Sponsor: MIPO Clinic • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
New ointment could treat larger patches of Sun-Damaged skin
Disease control CompletedThis study tested an ointment called tirbanibulin (Klisyri®) on adults with actinic keratosis, a common precancerous skin condition caused by sun exposure. The trial included 280 participants and applied the ointment to larger skin areas (up to 100 cm²) on the face or balding sca…
Phase: PHASE3 • Sponsor: Almirall, S.A. • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Can texting and cash help young people with HIV stay healthy?
Disease control CompletedThis study in Kenya tests different behavioral strategies to help 880 adolescents and young adults (ages 14-24) with HIV stay engaged in care. Participants first get either standard care or electronic navigation. If they miss appointments or have unsuppressed virus, they are re-r…
Phase: NA • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
New program aims to tackle HIV stigma and depression in teens
Disease control CompletedThis study tests a program called Project YES+ for youth aged 15-21 living with HIV in Zambia. The program combines peer mentoring with mental health support to reduce stigma, violence, and depression. Researchers will enroll 400 participants to see if the program is feasible and…
Phase: NA • Sponsor: Johns Hopkins Bloomberg School of Public Health • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Could a cup of green tea keep colon cancer away?
Disease control CompletedThis pilot study tests whether a purified green tea extract called EGCG can help prevent colon cancer from coming back after surgery. 51 patients who had their colon cancer removed took either the extract or a placebo. Researchers are checking for changes in DNA methylation, a ma…
Phase: EARLY_PHASE1 • Sponsor: The University of Texas Health Science Center at San Antonio • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Can interferon keep melanoma from coming back after surgery?
Disease control CompletedThis completed phase 2 trial tested whether adding alpha interferon to standard surgery helps prevent skin melanoma from returning. 278 participants with stage I-IV melanoma were assigned to one of six groups, including surgery alone, low or high dose interferon, chemotherapy, or…
Phase: PHASE2 • Sponsor: MIPO Clinic • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Mobile clinic brings HIV treatment to the streets: Same-Day start could transform care for the excluded
Disease control CompletedThis study tests a new way to help vulnerable people with HIV get diagnosed and start treatment right away using a mobile screening unit. Participants receive the once-daily pill Biktarvy on the same day they are enrolled. The goal is to see if this approach helps them stay in ca…
Phase: PHASE4 • Sponsor: Fundacion SEIMC-GESIDA • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Should HIV treatment start right away? new study tests timing
Disease control CompletedThis study looked at whether starting antiretroviral therapy (ART) immediately (within 48 hours) versus waiting until an opportunistic infection is under control affects death rates in HIV/AIDS patients hospitalized with such infections. Researchers enrolled 114 adults with HIV a…
Phase: NA • Sponsor: Gustavo Reyes-Teran • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
New drug duo aims to shrink prostate tumors before surgery
Disease control CompletedThis study tests two drugs, saruparib and darolutamide, given alone or together before prostate removal surgery in men with newly diagnosed prostate cancer. The goal is to see how these drugs affect cancer cells and check for side effects. About 120 men with localized, higher-ris…
Phase: PHASE1 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Immunotherapy drug durvalumab may be safe for liver cancer patients with active hepatitis b
Disease control CompletedThis study tests whether the immunotherapy drug durvalumab can be safely given to people with advanced liver cancer who also have an active hepatitis B infection. All participants receive an antiviral drug (entecavir) to control the hepatitis B virus. The main goal is to see if d…
Phase: PHASE2 • Sponsor: National Taiwan University Hospital • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
New hope for rare blood disorder: experimental pill reduces need for transfusions
Disease control CompletedThis study tested a drug called bitopertin in 15 adults with Diamond-Blackfan anemia (DBA), a rare inherited condition that causes severe anemia. Participants took the pill daily for 8 months, with doses possibly increasing over time. The goal was to see if the drug could raise h…
Phase: PHASE1, PHASE2 • Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Could a zapping suit boost weight loss? new study tests muscle stimulation and diet
Disease control CompletedThis study investigates whether adding whole-body electrical muscle stimulation (WB-EMS) to a calorie-restricted diet improves body composition and metabolic health in women with obesity. Participants follow an 8-week diet plan, with half also receiving twice-weekly 20-minute WB-…
Phase: NA • Sponsor: Firat University • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Triple immunotherapy attack shows promise against Hard-to-Treat HPV cancers
Disease control CompletedThis study tests a combination of three immunotherapy drugs—PDS0101, M7824, and NHS-IL12—in people with advanced HPV-related cancers such as cervical, anal, and throat cancers. The goal is to see if the mix can shrink tumors or stop them from growing. Participants receive the dru…
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Could a Protein-Rich diet and strength training boost heart recovery?
Disease control CompletedThis study explores whether combining a high-protein Mediterranean diet with resistance exercise can help people with heart disease build muscle and lower their risk of future heart problems. The trial enrolls adults who have completed cardiac rehab and may have low muscle mass w…
Phase: NA • Sponsor: Liverpool John Moores University • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
New drug combo aims to stall prostate cancer in chinese men
Disease control CompletedThis study tests whether adding darolutamide to standard hormone therapy (ADT) helps Chinese men with a high-risk form of prostate cancer that has not spread but is no longer responding to hormone therapy alone. Darolutamide blocks the effects of male hormones on cancer cells, po…
Phase: PHASE2 • Sponsor: Bayer • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
New eye drug aims to save sight in wet AMD
Disease control CompletedThis trial tests whether an experimental drug called ONS-5010 (a form of bevacizumab) works as well as an approved drug, Lucentis, for treating wet age-related macular degeneration (AMD). Wet AMD causes rapid vision loss due to abnormal blood vessels leaking fluid in the eye. Abo…
Phase: PHASE3 • Sponsor: Outlook Therapeutics, Inc. • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
New program helps trans women with HIV achieve viral suppression
Disease control CompletedThis study tested a program called Gender-affirming Abriendo Puertas for transgender women living with HIV in Santo Domingo. The program included individual counseling, peer support, and community activities to help participants stay on HIV medication and achieve viral suppressio…
Phase: NA • Sponsor: University of North Carolina, Chapel Hill • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
IV iron may beat pills for anemia in late pregnancy
Disease control CompletedThis study tests whether a single intravenous dose of ferumoxytol raises hemoglobin more effectively than daily oral ferrous sulfate in pregnant women with iron deficiency anemia. Participants are between 24 and 34 weeks pregnant with a single baby. The trial measures hemoglobin …
Phase: PHASE3 • Sponsor: Stanford University • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Old chemo drug gets new partner in fight against lung cancer
Disease control CompletedThis phase II trial tests whether a low-dose, frequent schedule of the chemotherapy drug vinorelbine, taken orally, can boost the effects of the immunotherapy atezolizumab in people with stage IV non-small cell lung cancer. The study enrolls adults whose cancer has progressed aft…
Phase: PHASE2 • Sponsor: University Hospital, Brest • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Fish oil and remote rehab: a new hope for long COVID sufferers?
Disease control CompletedThis study tests whether a combination of a special omega-3 supplement (LIPINOVA®) and a home-based exercise and education program can improve quality of life for people with lingering post-COVID symptoms. About 146 adults aged 18–70 who have had symptoms for more than 12 weeks w…
Phase: NA • Sponsor: Instituto de Investigación Sanitaria Aragón • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
New combo therapy aims to stop liver cancer from coming back
Disease control CompletedThis study tests whether adding a targeted drug (Donafenib) and chemotherapy directly into the liver's blood supply can prevent liver cancer from returning after surgery. It includes adults with a single large tumor (≥5 cm) and microscopic blood vessel invasion, who are at high r…
Phase: PHASE2 • Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Can an arthritis drug tame brain inflammation in Alzheimer's and ALS?
Disease control CompletedThis early-phase study tested the drug baricitinib in 17 people with Alzheimer's disease, ALS, or mild cognitive problems. The goal was to see if the drug reaches the brain and lowers inflammation linked to these diseases. Participants took baricitinib pills for 24 weeks, and res…
Phase: PHASE1, PHASE2 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
New pill takes aim at 'Undruggable' cancer mutation
Disease control CompletedThis study tests a drug called sotorasib in people with advanced solid tumors that have a specific genetic change (KRAS G12C). The trial has two phases: first to find the safest dose, then to see how well it shrinks tumors. About 713 adults with various cancers, including lung ca…
Phase: PHASE1, PHASE2 • Sponsor: Amgen • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
One patient gets experimental enzyme to fight rare kidney disease
Disease control CompletedThis study tested an artificial version of the LCAT enzyme (ACP-501) in one person with familial LCAT deficiency, a rare genetic condition that leads to low 'good' cholesterol and kidney failure. The participant received several infusions of the drug over weeks, with regular bloo…
Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Family-Focused weight program aims to tackle obesity in kids with type 1 diabetes
Disease control CompletedThis study tests a family-based behavioral program for youth aged 6-17 with type 1 diabetes who are overweight or obese, along with an overweight parent. The program focuses on healthy meal planning, food literacy, and family habits to improve weight and diabetes control. Twenty …
Phase: NA • Sponsor: State University of New York at Buffalo • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
New hope for kids with liver cancer: personalized treatment shows promise
Disease control CompletedThis study tests a treatment plan tailored to each child's risk level for a rare liver cancer called hepatoblastoma. About 236 children will receive standard treatments like surgery and chemotherapy, plus the drug temsirolimus for high-risk cases. The goal is to see if this appro…
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Nanoparticle chemo and DNA-Repair blocker join forces against tough cancers
Disease control CompletedThis trial investigates a combination of two drugs: EP0057, a chemotherapy drug wrapped in a nanoparticle to help it reach cancer cells, and olaparib, which stops cancer cells from fixing DNA damage. The study includes adults with small cell lung cancer, bladder cancer, or prosta…
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Off-the-Shelf immune cells take on tough lymphoma
Disease control CompletedThis early-stage trial is testing a new treatment called ACE1831 for adults with B-cell lymphoma that has come back or not responded to at least two prior treatments. ACE1831 uses immune cells from healthy donors that are modified to target and kill cancer cells. The study aims t…
Phase: PHASE1 • Sponsor: Acepodia Biotech, Inc. • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Community strategies show promise in curbing hazardous drinking
Disease control CompletedThis study tests a 5-week community-based program that teaches protective behavioral strategies to reduce alcohol use in men aged 35–44 with hazardous drinking habits in rural Vietnam. Participants learn to set safe drinking limits, choose nonalcoholic drinks, and plan ahead, wit…
Phase: NA • Sponsor: Chulalongkorn University • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Can diet and activity classes help Moms-to-Be avoid excess weight gain?
Disease control CompletedThis study tested two lifestyle programs for overweight or obese pregnant women to help them manage weight gain during pregnancy. One group received weekly group sessions on diet and activity, while the other got extra health information and classes. Researchers tracked weight ga…
Phase: PHASE3 • Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
New drug naderin may help patients fight infections during cancer and TB therapy
Disease control CompletedThis study tested whether adding Naderin (sodium nucleinate) to standard treatment could reduce complications in 75 patients with cancer, tuberculosis, or hepatitis C. The main group received Naderin plus standard therapy, while the control group received standard therapy alone. …
Phase: PHASE2, PHASE3 • Sponsor: MIPO Clinic • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
New study pits tiny valve fix against major surgery for heart valve failure
Disease control CompletedThis study compared two ways to fix a failed mitral heart valve replacement: a less invasive procedure called valve-in-valve (using a catheter to place a new valve inside the old one) versus repeat open-heart surgery. The trial included 150 adults with severe valve problems. Rese…
Phase: NA • Sponsor: Instituto Dante Pazzanese de Cardiologia • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Poop pills from different donors: a new hope for ulcerative colitis?
Disease control CompletedThis study tested fecal microbiota transplantation (FMT) from different donors to treat ulcerative colitis, a type of inflammatory bowel disease. Researchers gave 102 patients a one-time colonoscopic infusion of fresh fecal bacteria from healthy donors. The goal was to see if don…
Phase: NA • Sponsor: First Affiliated Hospital of Kunming Medical University • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Immunotherapy-Targeted therapy combo shows promise for advanced liver cancer
Disease control CompletedThis clinical trial is testing a combination of two drugs—an immunotherapy (pembrolizumab/quavonlimab) and a targeted therapy (lenvatinib)—as a first treatment for people with advanced hepatocellular carcinoma, a type of liver cancer that cannot be removed by surgery. The study a…
Phase: PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Could when you eat help control diabetes? new study tests meal timing vs. calorie counting
Disease control CompletedThis trial investigates whether changing how often and when people with type 2 diabetes eat can improve weight, blood sugar, and cholesterol. Over 12 weeks, participants follow one of three eating plans: a standard 6-meal diet, a 3-meal diet, or time-restricted eating (eating all…
Phase: NA • Sponsor: Akdeniz University • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Could a simple supplement make chemo work better for advanced colon cancer?
Disease control CompletedThis trial investigates whether adding a dietary supplement called sodium nucleinate to standard FOLFOX chemotherapy helps people with metastatic colorectal cancer (cancer that has spread). Participants are randomly assigned to receive either the supplement or a placebo alongside…
Phase: PHASE2, PHASE3 • Sponsor: MIPO Clinic • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
New hope for frail AML patients: stronger chemo regimens tested
Disease control CompletedThis study tests whether giving full-strength chemotherapy (either CPX-351 or a combination called CLAG-M) can help medically less-fit adults with acute myeloid leukemia live longer and achieve remission. About 60 participants will receive one of the two treatments. The goal is t…
Phase: PHASE2 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Could a common arthritis drug help fight recurrent brain cancer?
Disease control CompletedThis study tests whether Tofacitinib, a drug used for arthritis, can slow tumor growth in people with recurrent glioblastoma (a type of brain cancer). About 17 adults whose cancer returned after standard treatment will take Tofacitinib pills twice daily. The goal is to see if it …
Phase: PHASE3 • Sponsor: University of Texas Southwestern Medical Center • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Could a Low-Carb diet help fight endometrial cancer?
Disease control CompletedThis study looks at whether a ketogenic diet—a very low-carbohydrate diet that forces the body to burn fat for energy—is safe and tolerable for overweight or obese women with newly diagnosed endometrial cancer before they have surgery. Nineteen participants will either follow the…
Phase: NA • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
HIV-Fighting cells show promise in lymphoma treatment
Disease control CompletedThis study tested a new approach for people with both HIV and lymphoma. After high-dose chemotherapy and a stem cell transplant, participants received specially grown HIV-fighting immune cells (HST-NEETs). The goal was to see if giving these cells was feasible and if they could r…
Phase: PHASE2 • Sponsor: Catherine Bollard • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Melanoma patients get drug combo before surgery in new trial
Disease control CompletedThis phase II trial tests whether giving two targeted drugs (dabrafenib and trametinib) before and after surgery can improve outcomes for people with stage IIIB-C melanoma that has a BRAF V600 mutation. 35 participants will take the drugs for 12 weeks before surgery, then continu…
Phase: PHASE2 • Sponsor: Melanoma Institute Australia • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Heartburn drug could ease painful sun sensitivity
Disease control CompletedThis Phase 2 trial tested whether oral cimetidine (Tagamet), a common heartburn drug, can reduce light sensitivity in people with erythropoietic protoporphyria (EPP) and X-linked protoporphyria (XLP). These genetic conditions cause severe pain from sunlight exposure. The study en…
Phase: PHASE2 • Sponsor: Amy K. Dickey, M.D. • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Could a common steroid save kids from septic shock?
Disease control CompletedThis study looks at giving the steroid hydrocortisone early to children (ages 2 months to 12 years) with septic shock. The goal is to see if it lowers the chance of death within 28 days and shortens time on blood pressure medicines and in the ICU. About 122 children will take par…
Phase: NA • Sponsor: Muhammad Aamir Latif • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Immunotherapy duo before liver surgery shows promise against cancer
Disease control CompletedThis trial investigates whether giving two immunotherapy drugs, ipilimumab and nivolumab, before liver surgery can help shrink tumors in people with liver cancer (hepatocellular carcinoma). Participants receive the drugs in the weeks leading up to their planned surgery. The study…
Phase: PHASE1, PHASE2 • Sponsor: Imperial College London • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Massive study of 99,000 people tests Paxlovid's Real-World power against severe COVID
Disease control CompletedThis study looks at health records from about 99,000 adults in Ontario who had COVID-19 and visited a pharmacist. It compares those who got Paxlovid (nirmatrelvir-ritonavir) with those who didn't, to see if the drug lowers the chance of hospitalization, ICU admission, or death wi…
Sponsor: Pfizer • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
One-Stop health check: can integrated care tame HIV and heart disease together?
Disease control CompletedThis trial tests a package of services called TASKPEN, which combines HIV care with screening and treatment for high blood pressure, diabetes, and tobacco use. It involves over 5,700 adults living with HIV in Lusaka, Zambia. The goal is to see if this integrated approach helps mo…
Phase: NA • Sponsor: University of North Carolina, Chapel Hill • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Can a better diet during malnutrition recovery rewire a Child's brain?
Disease control CompletedThis study looks at whether specially designed nutritional supplements can improve thinking skills and emotional control in young children in Bangladesh who have moderate malnutrition. About 300 children aged 1 to 3 years receive either standard or enhanced nutritional supplement…
Phase: NA • Sponsor: Boston Children's Hospital • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Could a month of iron before knee or hip surgery cut transfusion risk?
Disease control CompletedThis trial investigates whether anemic patients scheduled for hip or knee replacement surgery benefit from taking an iron supplement (Sideremil Vita) for 30 days before the operation, compared to taking it for only 15 days. The goal is to see if the longer treatment reduces the n…
Phase: NA • Sponsor: I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
New drug targets genetic weakness in Hard-to-Treat blood cancers
Disease control CompletedThis study tests a drug called FT-2102 (olutasidenib) in people with acute myeloid leukemia or myelodysplastic syndrome whose cancers have a specific IDH1 gene mutation. The drug is given alone or combined with standard chemotherapy drugs (azacitidine or cytarabine). The goal is …
Phase: PHASE1, PHASE2 • Sponsor: Forma Therapeutics, Inc. • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Vitamin d may unlock iron absorption in IBD patients
Disease control CompletedThis study investigates whether giving vitamin D supplements to adults with inflammatory bowel disease (Crohn's disease or ulcerative colitis) who also have low vitamin D levels can improve their iron status. Participants take high-dose vitamin D3 weekly for 8 weeks, then a lower…
Phase: PHASE4 • Sponsor: Gazi University • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
New combo shows promise against tough breast cancer
Disease control CompletedThis phase 2 trial tested whether adding carboplatin and/or bevacizumab to standard chemotherapy before surgery helps shrink tumors in people with a hard-to-treat type of breast cancer (hormone receptor-poor, HER2-negative, including triple-negative). 454 participants received we…
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
New pill shows promise for Hard-to-Treat blood cancers in japanese patients
Disease control CompletedThis study tests a drug called acalabrutinib in Japanese adults with advanced B-cell blood cancers (like leukemia and lymphoma). The goal is to see if it is safe and helps control the cancer. Participants take the drug daily, and researchers monitor side effects and how well the …
Phase: PHASE1 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Stool transplants via stoma show promise for treating Post-Surgery colon inflammation
Disease control CompletedThis study tests whether giving patients their own stool bacteria through a temporary stoma can reduce inflammation in the unused part of the colon, a condition called diversion colitis. Sixty-six people with rectal cancer who have a temporary ileostomy will receive either a dail…
Phase: NA • Sponsor: Yongjian Liao • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Immunotherapy and chemotherapy join forces to fight recurrent ovarian cancer
Disease control CompletedThis phase II trial tests whether combining the immunotherapy drug pembrolizumab (Keytruda) with the chemotherapy drug carboplatin can prevent ovarian, fallopian tube, or primary peritoneal cancer from progressing after a blood test shows it may have returned. The study includes …
Phase: PHASE2 • Sponsor: University of Washington • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
New lung cancer pill shows promise in Head-to-Head trial
Disease control CompletedThis Phase 3 trial tested a new targeted therapy, lazertinib, against the standard drug gefitinib in 393 people with advanced EGFR-mutated non-small cell lung cancer. The goal was to see if lazertinib could keep cancer from growing longer. Participants took either lazertinib or g…
Phase: PHASE3 • Sponsor: Yuhan Corporation • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
New combo approach for kidney cancer shows promise in early trial
Disease control CompletedThis study tested a two-step treatment for medium-sized kidney tumors (4.1-7 cm). First, doctors blocked the tumor's blood supply, then froze it. The goal was to see if this approach is safe and works well. 25 adults with stage T1b kidney cancer took part. The main focus was on s…
Phase: NA • Sponsor: University of Alabama at Birmingham • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Experimental drug aims to tame severe COVID-19 inflammation
Disease control CompletedThis study tests an experimental drug called SPI-1005 (ebselen) in adults hospitalized with severe COVID-19. Participants receive either the drug or a placebo to see if the drug is safe and helps improve recovery. The trial is randomized and double-blind, meaning neither patients…
Phase: PHASE2 • Sponsor: Sound Pharmaceuticals, Incorporated • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Study tests skipping extra treatment for early breast condition
Disease control CompletedThis study looks at whether removing a small, low-grade breast change called DCIS with surgery alone is enough. About 158 people with grade 1 or 2 DCIS are being followed to see if the condition comes back. The goal is to find out if some patients can avoid additional treatments …
Phase: PHASE2 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
New device aims to simplify bowel surgery
Disease control CompletedThis study is testing a new device called SEGER IDEA™ that helps surgeons close openings in the bowel during keyhole surgery. It is the first time this device is being used in humans. Ten adults having certain types of bowel surgery will take part. The main goal is to see if the …
Phase: NA • Sponsor: Seger Surgical Solutions • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Could a targeted drug shrink advanced cervical tumors?
Disease control CompletedThis phase 2 trial tests the drug cabozantinib in women with advanced or metastatic cervical cancer that has worsened after platinum-based chemotherapy. The study aims to see if cabozantinib can control the disease and how safe it is, particularly regarding risks like fistulas. P…
Phase: PHASE2 • Sponsor: Centre Francois Baclesse • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
New combo therapy shows promise against advanced melanoma before surgery
Disease control CompletedThis study tested a new approach for people with advanced melanoma that can be surgically removed. Participants received a combination of two immunotherapies: one injected directly into the tumor (Tavo) and one given through a vein (nivolumab). After 12 weeks, they had surgery to…
Phase: PHASE2 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
New drug combo shows promise in liver cancer trial
Disease control CompletedThis phase 2 trial tested whether adding an experimental drug called SRF388 to a standard two-drug regimen (atezolizumab plus bevacizumab) helps people with advanced liver cancer that hasn't been treated before. The study enrolled 30 adults whose cancer could not be surgically re…
Phase: PHASE2 • Sponsor: Coherus Oncology, Inc. • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Major trial pits three chemo drugs against each other for advanced breast cancer
Disease control CompletedThis large phase III trial tests which of three chemotherapy drugs—paclitaxel, nab-paclitaxel, or ixabepilone—works best, with or without the targeted drug bevacizumab, for people with stage IIIC or IV breast cancer that has returned or spread. The study aims to find the most eff…
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
New antibody aims to calm ulcerative colitis when other treatments fail
Disease control CompletedThis phase 2 trial tests whether OSE-127, an antibody that blocks a key immune signal, can reduce disease activity in people with moderate to severe ulcerative colitis who have not responded to or cannot tolerate previous treatments. Participants are randomly assigned to receive …
Phase: PHASE2 • Sponsor: OSE Immunotherapeutics • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Hope for rare liver disease: drug aims to ease severe itching in children
Disease control CompletedThis study tests the long-term safety of maralixibat, an oral medication, in children with progressive familial intrahepatic cholestasis (PFIC), a rare liver disease that causes intense itching. Participants who completed a prior study will receive maralixibat twice daily. Resear…
Phase: PHASE3 • Sponsor: Mirum Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Can a common antibiotic beat yaws? new trial puts linezolid to the test
Disease control CompletedThis phase 3 trial investigates whether the antibiotic linezolid can cure yaws, a bacterial skin infection that causes ulcers, as effectively as the standard treatment azithromycin. The study involves 384 children aged 5 to 18 with confirmed yaws. Participants receive either line…
Phase: PHASE3 • Sponsor: Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Battle of the lenses: which contact lens best fights childhood nearsightedness?
Disease control CompletedThis trial tests two different contact lenses designed to slow down the progression of myopia (nearsightedness) in children aged 6 to 11. Each child wears one type of lens on each eye for six months, then switches, so researchers can compare how well each lens controls eye growth…
Phase: NA • Sponsor: Essilor International • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Targeted drug shows promise for Gene-Driven lung cancers
Disease control CompletedThis phase 2 trial tests the drug crizotinib (XALKORI) in people with advanced non-small cell lung cancer that has spread and carries a change in the ROS1 or MET gene. Participants take crizotinib by mouth twice daily. The study aims to see how well the drug shrinks tumors and de…
Phase: PHASE2 • Sponsor: University Health Network, Toronto • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Could a targeted drug keep AML in check?
Disease control CompletedThis phase III trial tests whether the drug tipifarnib can prevent acute myeloid leukemia (AML) from coming back in patients who are already in remission. Participants include adults over 60 in first remission, those in second or later remission, or those who achieved remission a…
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Lung cancer drug shows promise in keeping tumors at bay after chemo
Disease control CompletedThis phase III trial investigates whether sunitinib, a drug that blocks tumor blood vessel growth, can help patients with advanced non-small cell lung cancer maintain their response after initial chemotherapy. Participants who did not worsen after four cycles of platinum-based ch…
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Can exercise tweak tumor biology? new trial tests aerobic vs. resistance training in breast cancer
Disease control CompletedThis trial investigates whether structured exercise—either aerobic cycling or resistance training—can improve health-related biomarkers in women with breast cancer undergoing neoadjuvant therapy (chemotherapy or endocrine therapy before surgery). The main focus is on changes in K…
Phase: NA • Sponsor: Fundacao Champalimaud • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Can a blend of lemon verbena and saffron curb emotional eating?
Disease control CompletedThis study tests whether a dietary supplement called Satisens®, made from lemon verbena, hibiscus, saffron, and carob extract, can help reduce emotional eating and cravings for sweets in healthy adults who are overweight or obese. Participants take two capsules daily for a set pe…
Phase: NA • Sponsor: José Enrique de la Rubia Ortí, Ph • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Targeted therapy combo aims to improve survival in older leukemia patients
Disease control CompletedThis study tests whether adding the targeted drug inotuzumab ozogamicin to a milder chemotherapy regimen improves survival in adults over 55 with a specific type of acute lymphoblastic leukemia (ALL) that is Philadelphia chromosome-negative and CD22-positive. Participants receive…
Phase: PHASE2 • Sponsor: Versailles Hospital • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Pacemaker tweak may quietly lower blood pressure without extra pills
Disease control CompletedThis trial tests a special pacemaker called the BackBeat Moderato that can adjust its pacing to help control high blood pressure. Researchers will turn the device on and off for short periods in 28 people who already have the pacemaker implanted, measuring how their blood pressur…
Phase: PHASE1, PHASE2 • Sponsor: BackBeat Medical Inc • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Can hypnosis help when Weight-Loss surgery fails?
Disease control CompletedThis trial investigates whether adding hypnosis sessions to standard dietary monitoring can help people lose weight after bariatric surgery has not worked. About 25% of patients do not achieve lasting weight loss from surgery alone. The study enrolls 60 adults aged 18-65 with obe…
Phase: NA • Sponsor: University Hospital, Montpellier • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Could changing when you eat protein help parkinson symptoms?
Disease control CompletedThis pilot study explores whether the timing and amount of protein in meals can help preserve muscle health and improve sleep in people with Parkinson disease. Participants follow either a protein redistribution diet (low protein during the day, high protein at dinner) or a prote…
Phase: NA • Sponsor: University of Alabama at Birmingham • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Engineered stem cells aim to speed recovery in blood cancer patients
Disease control CompletedThis trial tests omidubicel, an experimental stem cell transplant, for people with high-risk blood cancers like leukemia or lymphoma. The goal is to see if it helps the body rebuild its immune system faster after transplant. Participants receive omidubicel along with standard tra…
Phase: PHASE3 • Sponsor: Gamida Cell ltd • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Robot or scalpel? european trial tests less invasive pancreatic cancer surgery
Disease control CompletedThis trial compares two types of surgery for pancreatic cancer in the body or tail of the pancreas: minimally invasive (laparoscopic or robot-assisted) versus traditional open surgery. The goal is to see if the less invasive approach can remove the tumor just as completely. Adult…
Phase: NA • Sponsor: University Hospital, Montpellier • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Rapid Finger-Prick test could help shield cancer patients from COVID-19
Diagnosis CompletedThis study tested a quick finger-prick blood test to see if cancer patients had been infected with COVID-19 in the past. Researchers enrolled 214 adults being treated for cancer. The goal was to find out how many had antibodies, including those without symptoms, to help clinics k…
Phase: NA • Sponsor: Centre Antoine Lacassagne • Aim: Diagnosis
Last updated Jul 04, 2026 00:00 UTC
-
No more tubes? swallowable capsule could revolutionize stomach acid testing
Diagnosis CompletedThis study tests a new, less invasive way to measure stomach acid using a small wireless capsule (SmartPill) that patients swallow. It compares the capsule's accuracy to the standard method, which involves a tube placed through the nose into the stomach. The study includes health…
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Diagnosis
Last updated Jul 04, 2026 00:00 UTC
-
AI may allow safer breast MRIs with lower contrast doses
Diagnosis CompletedThis study tested whether artificial intelligence (AI) can help doctors accurately identify breast tumors on MRIs that use a lower dose of gadolinium contrast dye. Reducing the dose may lower the amount of gadolinium deposited in the brain. The study included 20 women—half with b…
Phase: PHASE1 • Sponsor: University of Alabama at Birmingham • Aim: Diagnosis
Last updated Jul 03, 2026 00:00 UTC
-
Simple blood or urine test could spot kidney cancer early
Diagnosis CompletedThis study collects blood, tissue, and urine from about 589 people with different types of kidney or urinary tract tumors, plus healthy volunteers. Researchers are looking for special DNA markers (methylated DNA) that could help detect these cancers earlier and more accurately. T…
Sponsor: Mayo Clinic • Aim: Diagnosis
Last updated Jul 03, 2026 00:00 UTC
-
Could a smartphone camera spot blinding eye diseases?
Diagnosis CompletedThis study tests whether a smartphone-based camera can accurately screen for eye diseases such as diabetic retinopathy, glaucoma, and age-related macular degeneration. About 550 patients will have photos taken with both the smartphone camera and standard equipment. Ophthalmologis…
Sponsor: University of Michigan • Aim: Diagnosis
Last updated Jul 01, 2026 00:00 UTC
-
AI reads MRI scans to spot brain tumors without surgery
Diagnosis CompletedThis study tests whether an artificial intelligence system called GliomaAI-Astro23 can identify a specific type of brain tumor (IDH mutant astrocytoma) from routine MRI scans. Researchers are using existing MRI data from 1,372 patients to train and evaluate the AI. If accurate, t…
Sponsor: Deep Learning Institute of Radiological Sciences • Aim: Diagnosis
Last updated Jul 01, 2026 00:00 UTC
-
AI reads MRI scans to spot a deadly brain tumor type without surgery
Diagnosis CompletedThis study tests whether an artificial intelligence system called GliomaAI-Astro4 can accurately detect a specific type of brain tumor (IDH mutant astrocytoma grade 4) using routine MRI scans. Researchers will analyze previously collected, anonymized MRI data from 1,372 patients …
Sponsor: Deep Learning Institute of Radiological Sciences • Aim: Diagnosis
Last updated Jul 01, 2026 00:00 UTC
-
AI reads brain scans to spot deadly tumors without surgery
Diagnosis CompletedThis study tests whether an artificial intelligence system called GliomaAI-GBM can detect a specific aggressive brain tumor (IDH wildtype glioblastoma) using routine MRI scans. Researchers will analyze previously collected, anonymized MRI data from 1,372 patients across 13 hospit…
Sponsor: Deep Learning Institute of Radiological Sciences • Aim: Diagnosis
Last updated Jul 01, 2026 00:00 UTC
-
Artificial intelligence reads brain scans to detect hidden tumor type
Diagnosis CompletedThis study tests whether an artificial intelligence system called GliomaAI-Oligo can detect a specific type of brain tumor (oligodendroglioma) from routine MRI scans. Researchers will use over 1,300 existing, anonymized scans from multiple hospitals to train and evaluate the AI. …
Sponsor: Deep Learning Institute of Radiological Sciences • Aim: Diagnosis
Last updated Jul 01, 2026 00:00 UTC
-
New SPECT scans could spot aggressive breast cancer without biopsy
Diagnosis CompletedThis study tests two new radioactive imaging agents, 99mTc-ADAPT6 and 99mTc-DARPinG3, to see how well they can detect HER2-positive breast cancer using SPECT scans. Fifteen women with HER2-positive breast cancer will receive injections of each agent a few days apart, followed by …
Phase: NA • Sponsor: Tomsk National Research Medical Center of the Russian Academy of Sciences • Aim: Diagnosis
Last updated Jul 01, 2026 00:00 UTC
-
Rapid STI test aims to curb antibiotic misuse
Diagnosis CompletedThis study compares a new rapid point-of-care test for chlamydia, gonorrhea, and mycoplasma genitalium to standard lab testing. The goal is to see if the faster test helps doctors give the right antibiotics on the same day, reducing unnecessary or missed treatments. Participants …
Phase: NA • Sponsor: Hoffmann-La Roche • Aim: Diagnosis
Last updated Jun 27, 2026 14:02 UTC
-
Can a camera replace the slit lamp for Post-Surgery eye checks?
Diagnosis CompletedThis trial compares a telemedical device called Occyo One to the standard slit lamp exam for detecting complications after cataract surgery. About 365 patients scheduled for cataract surgery will have their eyes imaged with Occyo One before and after surgery. A remote ophthalmolo…
Phase: NA • Sponsor: Medical University Innsbruck • Aim: Diagnosis
Last updated Jun 27, 2026 14:02 UTC
-
Campus sweep: rapid chagas tests could uncover thousands of hidden cases
Diagnosis CompletedThis study tests whether offering a rapid diagnostic test for Chagas disease at a university in Argentina can help find undiagnosed infections and connect people to treatment. Participants are students, faculty, and staff aged 18 and older who get a quick finger-prick test during…
Sponsor: Mundo Sano Foundation • Aim: Diagnosis
Last updated Jun 27, 2026 14:02 UTC
-
Tooth blood test could tell if a root canal is really needed
Diagnosis CompletedThis study looks at whether substances in the blood from a tooth's pulp can help dentists tell the difference between reversible pulpitis (a mild inflammation that can heal) and irreversible pulpitis (severe damage needing a root canal). Researchers will collect a small sample of…
Sponsor: Safa • Aim: Diagnosis
Last updated Jun 27, 2026 14:01 UTC
-
Can a pill shield ears from chemo damage?
Prevention CompletedThis study tests whether the drug SENS-401 can prevent hearing loss caused by cisplatin, a common chemotherapy. Adults with cancer who are scheduled to receive cisplatin take SENS-401 before, during, and after treatment. Hearing is measured with a standard test to see if the drug…
Phase: PHASE2 • Sponsor: Sensorion • Aim: Prevention
Last updated Jul 04, 2026 00:00 UTC
-
Phone coaching helps pregnant women avoid excess weight gain and diabetes
Prevention CompletedThis study tested a phone-based health coaching program for pregnant women with a higher body mass index. The goal was to help them gain a healthy amount of weight during pregnancy and prevent problems like gestational diabetes and later obesity in both mothers and children. Over…
Phase: NA • Sponsor: Johns Hopkins University • Aim: Prevention
Last updated Jul 04, 2026 00:00 UTC
-
Hospital push could shield seniors from preventable diseases
Prevention CompletedThis trial evaluates whether a hospital-based remedial vaccination strategy can improve Tdap-IPV (tetanus, diphtheria, pertussis, polio) vaccination rates in adults aged 65 and older in the Sarthe region of France. Participants are randomly assigned to receive either the remedial…
Phase: NA • Sponsor: Centre Hospitalier le Mans • Aim: Prevention
Last updated Jul 03, 2026 00:00 UTC
-
Could a laser beam stop chemo mouth sores?
Prevention CompletedThis trial investigates whether a low-level diode laser can prevent or reduce severe mouth sores (mucositis) caused by radiation and chemotherapy in people with advanced head and neck cancer. Participants receive either real laser therapy or a non-functional placebo laser during …
Phase: NA • Sponsor: Institut Cancerologie de l'Ouest • Aim: Prevention
Last updated Jul 03, 2026 00:00 UTC
-
Could a probiotic plus smart antibiotic use end the cycle of recurrent UTIs in children?
Prevention CompletedThis early-phase trial tests whether taking a daily probiotic (Saccharomyces boulardii) and using a targeted antibiotic (ciprofloxacin) only when a UTI occurs can reduce the number of repeat infections in children aged 2 to 17. Participants have had at least three UTIs in the pas…
Phase: EARLY_PHASE1 • Sponsor: Ann & Robert H Lurie Children's Hospital of Chicago • Aim: Prevention
Last updated Jul 03, 2026 00:00 UTC
-
Diabetes drugs may shield against Alzheimer's, massive global study hints
Prevention CompletedThis study analyzes health records from over 2 million adults across five continents to see if GLP-1 receptor agonists (like semaglutide and liraglutide) can lower the risk of developing Alzheimer's disease. It focuses on people aged 40 and older with type 2 diabetes or obesity, …
Sponsor: West China Hospital • Aim: Prevention
Last updated Jul 03, 2026 00:00 UTC
-
New counseling approach aims to boost HIV prevention in young black men who have sex with men
Prevention CompletedThis study tests a counseling program called ACTPrEP, designed to help young Black men who have sex with men (ages 18-34) start and continue taking PrEP, a daily pill that prevents HIV. The program uses acceptance and commitment therapy to address thoughts and feelings that might…
Phase: NA • Sponsor: Rhode Island Hospital • Aim: Prevention
Last updated Jul 03, 2026 00:00 UTC
-
Culturally tailored program aims to boost cervical cancer screening in black women
Prevention CompletedThis study tests a program called 'Health is Wealth: A Cervical Health Program' designed to encourage cervical cancer screening among African American and Sub-Saharan African immigrant women. Participants attend a two-hour educational session and receive an HPV self-sampling kit …
Phase: NA • Sponsor: Adebola Adegboyega • Aim: Prevention
Last updated Jul 03, 2026 00:00 UTC
-
Mindful movement may ward off anorexia in At-Risk college women
Prevention CompletedThis study tests whether an 8-week program combining gentle yoga and tai chi with acceptance-based techniques can lower the risk of developing anorexia nervosa in female college students who already have elevated body shape concerns. Participants are randomly assigned to the mind…
Phase: NA • Sponsor: Jinan University Guangzhou • Aim: Prevention
Last updated Jul 02, 2026 00:00 UTC
-
Kids' garden program could sow seeds for healthier futures
Prevention CompletedThis study tests a summer garden program called 'Summer Harvest Adventure' for children aged 8 to 11 from low-resource communities. The program teaches nutrition and healthy habits through gardening and cooking activities. Researchers will measure changes in fruit and vegetable i…
Phase: NA • Sponsor: Ohio State University • Aim: Prevention
Last updated Jul 02, 2026 00:00 UTC
-
New rabies shot shows promise in preventing deadly infection after bites
Prevention CompletedThis study tested a new medicine called SYN023 to prevent rabies in people who were bitten or scratched by animals like dogs or bats. About 448 adults with different levels of rabies risk received either SYN023 or the standard rabies immune globulin, along with the rabies vaccine…
Phase: PHASE2 • Sponsor: Synermore Biologics Co., Ltd. • Aim: Prevention
Last updated Jul 01, 2026 00:00 UTC
-
Simple toothbrushing lessons may slash radiation mouth pain for cancer patients
Prevention CompletedThis study tested whether giving head and neck cancer patients detailed oral hygiene and diet instructions can prevent painful mouth sores caused by radiation. 150 patients were split into two groups: one got standard advice, the other got step-by-step oral care training. Researc…
Phase: NA • Sponsor: West China Hospital • Aim: Prevention
Last updated Jul 01, 2026 00:00 UTC
-
Doctor's checklist may catch more colon cancers early
Prevention CompletedThis study tests whether giving general practitioners a list of patients who have not completed colorectal cancer screening encourages those patients to get screened. Over 48,000 patients aged 50-74 are involved, and their doctors either receive the list or do not. The goal is to…
Phase: NA • Sponsor: Nantes University Hospital • Aim: Prevention
Last updated Jun 27, 2026 14:02 UTC
-
Can a Nurse-Led education program calm heart surgery patients and speed recovery?
Symptom relief CompletedThis trial investigates whether a structured educational program led by nurses can reduce anxiety and improve outcomes for adults undergoing their first heart surgery. Participants are randomly assigned to receive either the nurse-led program or usual care. The program covers pre…
Phase: NA • Sponsor: Anna Farrús Torrella • Aim: Symptom relief
Last updated Jul 04, 2026 00:00 UTC
-
Timing of pain block during Weight-Loss surgery may cut opioid use
Symptom relief CompletedThis study looks at whether giving a nerve block (TAP block) early during laparoscopic sleeve gastrectomy reduces pain more than giving it later. About 200 adults having this weight-loss surgery will receive the same numbing medicine, but at different times. Researchers will comp…
Phase: NA • Sponsor: Arthur Carlin • Aim: Symptom relief
Last updated Jul 04, 2026 00:00 UTC
-
Single-Dose radiation during breast surgery: a new hope?
Symptom relief CompletedThis study tested a device called Papillon +TM that delivers a single dose of radiation directly to the tumor site during breast cancer surgery. 28 women aged 60 and older with early-stage breast cancer took part. The main goal was to see if the technique was feasible and safe, n…
Phase: NA • Sponsor: Centre Antoine Lacassagne • Aim: Symptom relief
Last updated Jul 04, 2026 00:00 UTC
-
Can a tablet game sharpen aging minds during breast cancer treatment?
Symptom relief CompletedThis study explores whether a tablet-based cognitive stimulation program called HAPPYNeuron® is practical for breast cancer patients aged 70 and older. Cancer treatments, especially chemotherapy, can cause memory and thinking problems, and older patients may be at higher risk. Th…
Phase: NA • Sponsor: Centre Francois Baclesse • Aim: Symptom relief
Last updated Jul 04, 2026 00:00 UTC
-
New prosthetic grows with kids: no more frequent replacements?
Symptom relief CompletedThis study is testing a new type of prosthetic leg for children aged 3 to 18 that can be easily adjusted as they grow. The device is designed to be fitted in a single session and adjusted by the wearer. Researchers will measure comfort, socket pressure, walking speed, and quality…
Phase: NA • Sponsor: University of Pennsylvania • Aim: Symptom relief
Last updated Jul 04, 2026 00:00 UTC
-
Could body awareness exercises ease anxiety in young adults?
Symptom relief CompletedThis trial explores whether a group-based psychomotor therapy—using breathing, relaxation, and body awareness exercises—can be a practical and acceptable way to help young adults (ages 18-35) with anxiety. The study focuses on whether people will join and stick with the program, …
Phase: NA • Sponsor: VIA University College • Aim: Symptom relief
Last updated Jul 04, 2026 00:00 UTC
-
Could a Two-Drug pain block ease recovery after colon cancer surgery?
Symptom relief CompletedThis trial compares two approaches to a nerve block (TAP block) for pain after colorectal cancer surgery. One group receives the standard numbing drug bupivacaine, while the other gets bupivacaine plus dexmedetomidine, a drug that may extend pain relief. The study measures pain s…
Sponsor: Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital • Aim: Symptom relief
Last updated Jul 04, 2026 00:00 UTC
-
Dance therapy may boost fitness and body image in teens with scoliosis
Symptom relief CompletedThis study investigates whether adding dance-based exercises to standard scoliosis therapy improves physical fitness, body image, and quality of life in adolescents with mild scoliosis. Twenty-four teens aged 10–18 with a spinal curve between 10 and 30 degrees will be randomly as…
Phase: NA • Sponsor: Atlas University • Aim: Symptom relief
Last updated Jul 04, 2026 00:00 UTC
-
Robotic arm could help people with paralysis regain independence at home
Symptom relief CompletedThis study tests whether a wheelchair-mounted robotic arm called Jaco helps people with tetraplegia perform daily tasks like grasping and reaching at home. Participants use the device for two months after training. Researchers measure changes in performance and satisfaction with …
Phase: NA • Sponsor: Association APPROCHE • Aim: Symptom relief
Last updated Jul 04, 2026 00:00 UTC
-
Exercise may boost memory in kids treated for brain cancer
Symptom relief CompletedThis study tested whether a 12-week physical activity program could improve memory and attention in children who had radiation for brain tumors. Thirty-six kids aged 8–17 who finished radiation at least a year ago took part. Half started the program right away, while the other ha…
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Symptom relief
Last updated Jul 04, 2026 00:00 UTC
-
Brain and body boost: could home-based cognitive and physical training ease 'chemo brain' after breast cancer?
Symptom relief CompletedThis study explores whether a 12-week program combining cognitive stimulation sessions and adapted physical activity, done at home with remote supervision, is feasible for women who have cognitive difficulties after breast cancer treatment. The study includes 20 women with locali…
Phase: NA • Sponsor: Centre Francois Baclesse • Aim: Symptom relief
Last updated Jul 04, 2026 00:00 UTC
-
Can bright light help lung cancer patients sleep better and age slower?
Symptom relief CompletedThis trial tests whether daily bright light therapy can improve sleep and reduce biological aging in people with lung cancer. Participants wear a light visor for 4 weeks and track sleep, fatigue, and stress. The study compares bright light to usual light exposure to see if it hel…
Phase: NA • Sponsor: Henry Ford Health System • Aim: Symptom relief
Last updated Jul 04, 2026 00:00 UTC
-
Can a plant compound help control blood sugar? new study explores Quercetin's effects
Symptom relief CompletedThis study looked at whether quercetin, a natural substance found in foods like apples and onions, can change how the body absorbs sugar. Researchers gave 24 obese adults (some with type 2 diabetes) either quercetin or a placebo during a sugar-drink test. They measured blood suga…
Phase: PHASE2 • Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Symptom relief
Last updated Jul 04, 2026 00:00 UTC
-
Pen and paper therapy: writing away social anxiety?
Symptom relief CompletedThis study tests whether writing about imagined future scenarios (worst-case, best-case, or neutral) can reduce social anxiety symptoms. 270 adults with elevated social anxiety will complete three online writing sessions over three weeks. Researchers will measure changes in anxie…
Phase: NA • Sponsor: University of Colorado, Boulder • Aim: Symptom relief
Last updated Jul 04, 2026 00:00 UTC
-
Mindfulness may ease distress in breast cancer radiotherapy
Symptom relief CompletedThis trial tests whether a four-week mindfulness program, delivered by a nurse, can reduce psychological distress and increase hope and mindfulness in women with breast cancer receiving radiotherapy. One hundred women who had mastectomy and are now undergoing radiotherapy are ran…
Phase: NA • Sponsor: Alexandria University • Aim: Symptom relief
Last updated Jul 03, 2026 00:00 UTC
-
Could a structured nursing program boost quality of life in advanced lung cancer?
Symptom relief CompletedThis trial investigates whether an 8-week systematic symptom management nursing program can improve quality of life, self-management skills, and psychological resilience in people with advanced (stage IIIB–IV) lung cancer. Participants are randomly assigned to receive either rout…
Phase: NA • Sponsor: Jie Zeng • Aim: Symptom relief
Last updated Jul 03, 2026 00:00 UTC
-
AR video may ease anxiety before heart catheterization
Symptom relief CompletedThis study tests whether watching an augmented reality (AR) educational video on a tablet can lower anxiety in people about to undergo cardiac catheterization, a common heart procedure. Participants in the experimental group view the AR video in addition to receiving standard pap…
Phase: NA • Sponsor: Chung Shan Medical University • Aim: Symptom relief
Last updated Jul 03, 2026 00:00 UTC
-
New hope for chronic hives sufferers: experimental drug EVO756 under study
Symptom relief CompletedThis study tests an experimental drug called EVO756 in 160 adults with moderate to severe chronic spontaneous urticaria (CSU), also known as chronic hives. Participants must have had hives for at least 3 months and not gotten enough relief from standard antihistamines. The goal i…
Phase: PHASE2 • Sponsor: Evommune, Inc. • Aim: Symptom relief
Last updated Jul 03, 2026 00:00 UTC
-
New combo could delay painful mouth sores in cancer radiation
Symptom relief CompletedThis study tested whether adding thalidomide to glutamine can delay the onset of severe mouth sores caused by radiation therapy. 138 oral cancer patients were randomly assigned to receive either the combination or glutamine alone during their radiation treatment. The main goal wa…
Phase: PHASE3 • Sponsor: Air Force Military Medical University, China • Aim: Symptom relief
Last updated Jul 03, 2026 00:00 UTC
-
Could a smartphone program ease Chemo's emotional toll?
Symptom relief CompletedThis trial tests whether a nurse-led communication support program delivered via mobile health tools can improve quality of life and reduce anxiety and depression in women with early-stage breast cancer starting chemotherapy. Participants are randomly assigned to receive either t…
Phase: NA • Sponsor: National Defense Medical Center, Taiwan • Aim: Symptom relief
Last updated Jul 03, 2026 00:00 UTC
-
Stress ball soothes Moms-to-Be during baby heart monitoring
Symptom relief CompletedThis study tested whether using a stress ball during a routine fetal checkup (non-stress test) helps pregnant women feel less anxious and more comfortable. 70 pregnant women participated. The goal was to see if this simple, drug-free tool can improve the testing experience for mo…
Phase: NA • Sponsor: Gaziantep Islam Science and Technology University • Aim: Symptom relief
Last updated Jul 03, 2026 00:00 UTC
-
Which numbing cream eases laser pain best? new study puts two top contenders to the test
Symptom relief CompletedThis study tests two different numbing creams—one with lidocaine/prilocaine and another with lidocaine/tetracaine—against a placebo to see which works best for pain during Q-switched 532nm laser treatment for age spots (lentigines) and skin rejuvenation. Women aged 25 to 65 with …
Phase: EARLY_PHASE1 • Sponsor: Northwestern University • Aim: Symptom relief
Last updated Jul 03, 2026 00:00 UTC
-
Could relaxation techniques ease gut disorders? new study investigates
Symptom relief CompletedThis study tests whether a 9-week relaxation response mind-body program can improve quality of life and reduce symptoms in people with irritable bowel syndrome (IBS) or inflammatory bowel disease (IBD). Participants attend weekly group sessions that include breathing exercises, m…
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Symptom relief
Last updated Jul 03, 2026 00:00 UTC
-
Butchers' back pain targeted by new posture program
Symptom relief CompletedThis study tests whether a special posture training program can help butchers with neck and upper back pain. Researchers will enroll 50 butchers in Istanbul who have worked in the trade for at least 5 years. The program focuses on improving muscle control and posture. The goal is…
Phase: NA • Sponsor: Uskudar University • Aim: Symptom relief
Last updated Jul 03, 2026 00:00 UTC
-
Building better health: exercise and ergonomics trial for hardworking crews
Symptom relief CompletedThis study looks at whether adding simple exercises to ergonomics training can improve sleep, reduce burnout, and ease muscle pain in construction workers. About 52 men aged 25 to 55 who have had back, knee, neck, wrist, or shoulder pain for at least 3 months will take part. Part…
Phase: NA • Sponsor: Uskudar University • Aim: Symptom relief
Last updated Jul 03, 2026 00:00 UTC
-
New pain shot could cut opioid use after back surgery
Symptom relief CompletedThis study tests a new, long-lasting painkiller (liposomal bupivacaine) that works for up to 72 hours after spine surgery, compared to the standard 6-8 hour painkiller. About 204 adults having lower back surgery will be randomly assigned to receive one of the two painkillers. The…
Phase: PHASE4 • Sponsor: Min Li • Aim: Symptom relief
Last updated Jul 03, 2026 00:00 UTC
-
Mayo clinic tests personalized steroid dosing to tame pneumonia inflammation
Symptom relief CompletedThis study tests a personalized approach to giving the steroid dexamethasone to hospitalized adults with pneumonia. Instead of a standard dose, the amount is adjusted daily based on a blood marker called C-reactive protein (CRP). The goal is to reduce steroid side effects while s…
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Symptom relief
Last updated Jul 03, 2026 00:00 UTC
-
New study tests which root canal cleaning method hurts less
Symptom relief CompletedThis study looked at four different ways to activate the cleaning solution used during root canals: laser, sonic, ultrasonic, and simple needle irrigation. The goal was to see which method causes the least pain after the procedure and how much debris gets pushed out of the tooth.…
Phase: NA • Sponsor: Ain Shams University • Aim: Symptom relief
Last updated Jul 02, 2026 00:00 UTC
-
16-Hour fast may sharpen aging brains, small study hopes
Symptom relief CompletedThis study tests whether time-restricted eating (fasting for 16 hours each day) can improve memory, thinking, and overall well-being in overweight adults aged 65 and older who are worried about their memory. Over 24 weeks, participants either follow the fasting plan or join a hea…
Phase: NA • Sponsor: University of Florida • Aim: Symptom relief
Last updated Jul 02, 2026 00:00 UTC
-
Could a new pill help people who feel sleepy all day?
Symptom relief CompletedThis study tests an oral drug called SDX (serdexmethylphenidate) to see if it safely reduces excessive daytime sleepiness in adults with idiopathic hypersomnia, a condition where people feel extremely sleepy during the day despite getting enough sleep at night. Participants will …
Phase: PHASE2 • Sponsor: Zevra Therapeutics • Aim: Symptom relief
Last updated Jul 02, 2026 00:00 UTC
-
Family coaching boosts sleep apnea treatment use in kids with down syndrome
Symptom relief CompletedThis study looked at whether extra family support helps children with Down syndrome and obstructive sleep apnea use their positive airway pressure (PAP) machine more regularly. 27 children aged 6-18 were split into two groups: one received standard care, the other got a family-in…
Phase: NA • Sponsor: University of Miami • Aim: Symptom relief
Last updated Jul 02, 2026 00:00 UTC
-
Ice or steroid? simple rinse could ease root canal pain
Symptom relief CompletedThis study compares two final rinses inside the tooth after root canal treatment for people with severe tooth pain from irreversible pulpitis. One rinse is a cold saline solution (cryotherapy), the other is a steroid solution (dexamethasone). The goal is to see which better reduc…
Phase: PHASE4 • Sponsor: October 6 University • Aim: Symptom relief
Last updated Jul 02, 2026 00:00 UTC
-
Could a gel injection smooth away cellulite? new trial investigates
Symptom relief CompletedThis study tests whether ALIDYA, a gel injected into the skin, can improve the appearance of cellulite on the back of the thighs. Thirty women aged 20 to 45 with mild to moderate cellulite received six weekly treatments. Researchers used photos, ultrasound, and other imaging to m…
Phase: NA • Sponsor: Medical University of Silesia • Aim: Symptom relief
Last updated Jul 02, 2026 00:00 UTC
-
Beat the blues: drumming classes show promise for Parkinson's and Huntington's
Symptom relief CompletedThis study tested whether group drumming classes could improve quality of life and motor skills in people with Parkinson's or Huntington's disease. Eighteen participants took drum lessons twice a week for 12 weeks. Researchers measured changes in anxiety, depression, hand functio…
Phase: NA • Sponsor: Johns Hopkins University • Aim: Symptom relief
Last updated Jul 02, 2026 00:00 UTC
-
Wrist zap may tame tics: electrical pulses tested as Drug-Free option
Symptom relief CompletedThis trial tests whether rhythmic electrical pulses delivered to the wrist (median nerve stimulation) can reduce tics and the urge to tic in people with Tourette syndrome or chronic tic disorder. Participants wear a portable device for 15 minutes at a time over four weeks. The st…
Phase: NA • Sponsor: Nottingham University Hospitals NHS Trust • Aim: Symptom relief
Last updated Jul 02, 2026 00:00 UTC
-
Laparoscopic showdown: which surgical technique helps gastric cancer patients recover better?
Symptom relief CompletedThis trial compares two minimally invasive surgical techniques for removing the lower part of the stomach in people with gastric cancer: laparoscopy-assisted distal gastrectomy (LADG) and totally laparoscopic distal gastrectomy (TLDG). The goal is to see which approach leads to b…
Phase: NA • Sponsor: Fudan University • Aim: Symptom relief
Last updated Jul 02, 2026 00:00 UTC
-
Talking therapy tested for picky eating disorder in teens and young adults
Symptom relief CompletedThis trial tests whether a type of talking therapy called CBT-AR can help young people aged 12 to 25 with avoidant/restrictive food intake disorder (ARFID). ARFID is an eating disorder where people avoid certain foods or eat very little, not because of body image concerns but due…
Phase: NA • Sponsor: Orygen • Aim: Symptom relief
Last updated Jul 02, 2026 00:00 UTC
-
Can a smartphone app ease Pandemic-Era parent stress?
Symptom relief CompletedThis study tests whether a mindfulness app called Headspace can help low-income parents reduce stress, anxiety, and depression. Participants use the app on their own schedule for guided meditations. Researchers measure changes in stress and mood over time to see if the app provid…
Phase: NA • Sponsor: New York State Psychiatric Institute • Aim: Symptom relief
Last updated Jul 02, 2026 00:00 UTC
-
New adjustable brace shows promise for kids with crouch gait
Symptom relief CompletedThis study tested a new type of leg brace designed to help children with cerebral palsy and other movement disorders walk more easily. The brace was custom-made for each child and could be adjusted to provide different kinds of support. Researchers measured how well children walk…
Phase: NA • Sponsor: National Institutes of Health Clinical Center (CC) • Aim: Symptom relief
Last updated Jul 02, 2026 00:00 UTC
-
Can exercise help older adults with sickle cell disease?
Symptom relief CompletedThis study tested a personalized exercise program called Gerofit for older adults with sickle cell disease. The goal was to see if the program is safe, doable, and helps improve physical health and quality of life. Thirty participants took part in tele-exercise sessions focusing …
Phase: NA • Sponsor: Duke University • Aim: Symptom relief
Last updated Jul 02, 2026 00:00 UTC
-
Could tiny needles tame Chemo's Gut-Wrenching side effect in kids?
Symptom relief CompletedThis study tests whether acupuncture using tiny, semi-permanent needles can prevent diarrhea caused by the chemotherapy drug irinotecan in children with solid tumors. About 22 children will receive the acupuncture during their second round of chemo, and researchers will measure p…
Phase: NA • Sponsor: Fundació Sant Joan de Déu • Aim: Symptom relief
Last updated Jul 02, 2026 00:00 UTC
-
VR headsets tested to calm anxious parents at hospital bedside
Symptom relief CompletedThis study tested whether using a virtual reality headset showing calming scenery for 20-30 minutes could lower anxiety in parents whose children were in the hospital. 485 parents participated, and their anxiety levels were measured and compared to standard care without any tech-…
Phase: NA • Sponsor: Stanford University • Aim: Symptom relief
Last updated Jul 01, 2026 00:00 UTC
-
New cream and app aim to ease radiation burns for cancer patients
Symptom relief CompletedThis pilot study tests whether a special cream (KeraStat) and a mobile app (MyCap) can help manage skin rashes caused by radiation therapy in head and neck cancer patients. Sixteen participants will apply the cream at least twice daily during radiation and use the app to report t…
Phase: NA • Sponsor: Wake Forest University Health Sciences • Aim: Symptom relief
Last updated Jul 01, 2026 00:00 UTC
-
Breathing trick could sharpen lung cancer radiation
Symptom relief CompletedThis pilot study tests a breathing method called percussive ventilation breathhold (PVB) to help people hold still during lung cancer radiation. The goal is to see if the technique can be used successfully by healthy volunteers and lung cancer patients. If it works, it may allow …
Phase: NA • Sponsor: Stanford University • Aim: Symptom relief
Last updated Jul 01, 2026 00:00 UTC
-
Could virtual reality help kids with a rare muscle disease read emotions better?
Symptom relief CompletedThis study tests whether virtual reality training can help children aged 6 to 16 with the childhood form of myotonic dystrophy type 1 (DM1) improve their ability to understand others' thoughts and emotions. Participants engage in social scenarios in a virtual environment, guided …
Phase: NA • Sponsor: Institut de Myologie, France • Aim: Symptom relief
Last updated Jul 01, 2026 00:00 UTC
-
One dose during surgery may ease jaw pain and swelling
Symptom relief CompletedThis trial tests whether a single dose of the anti-inflammatory drug dexamethasone, given during jaw surgery, can lessen pain, swelling, and trouble opening the mouth afterward. About 60 people having wisdom tooth removal or cyst surgery under general anesthesia will take part. T…
Phase: PHASE4 • Sponsor: Selcuk University • Aim: Symptom relief
Last updated Jul 01, 2026 00:00 UTC
-
Online mindfulness program aims to ease chemo stress in breast cancer patients
Symptom relief CompletedThis study tests whether a 6-week online mindfulness program can lower stress, anxiety, and other side effects in women with breast cancer who are about to start chemotherapy. Two hundred participants will be randomly assigned to either the online mindfulness sessions or no extra…
Phase: NA • Sponsor: Medicos e Investigadores en la Lucha contra el Cancer de Mama • Aim: Symptom relief
Last updated Jul 01, 2026 00:00 UTC
-
Could water pilates help older women breathe easier and move better?
Symptom relief CompletedThis study compares two types of Pilates—one done in water and one on a mat—to see which better improves breathing, mobility, and quality of life in older women with a curved upper spine (kyphosis). Forty women aged 55 to 65 with mild to moderate kyphosis will follow a 12-week pr…
Phase: NA • Sponsor: University of Athens • Aim: Symptom relief
Last updated Jul 01, 2026 00:00 UTC
-
Could a Two-Session online therapy ease earthquake trauma?
Symptom relief CompletedThis trial tests whether a brief online group therapy called EMDR Flash can help adults who survived the 2023 Kahramanmaraş earthquakes in Türkiye. Participants receive two 60-90 minute group sessions via Zoom and are compared to a waitlist group. The study measures changes in PT…
Phase: NA • Sponsor: Istanbul Galata University • Aim: Symptom relief
Last updated Jul 01, 2026 00:00 UTC
-
Ketamine tested as new hope for long COVID brain fog and exhaustion
Symptom relief CompletedThis study tests whether ketamine can reduce fatigue and improve thinking in people with Long COVID. Twenty adults aged 18–65 with ongoing tiredness or brain fog will receive four ketamine injections over two weeks. Researchers will track changes in symptoms, brain scans, and inf…
Phase: PHASE2 • Sponsor: University of Texas at Austin • Aim: Symptom relief
Last updated Jul 01, 2026 00:00 UTC
-
Smartphone rehab after breast cancer surgery shows promise
Symptom relief CompletedThis study tested whether technology-based rehabilitation (telerehabilitation or a mobile app) could improve arm and shoulder function after breast cancer surgery, compared to standard physiotherapy. 45 women who had surgery with lymph node removal participated. The goal was to s…
Phase: NA • Sponsor: Medipol University • Aim: Symptom relief
Last updated Jul 01, 2026 00:00 UTC
-
Could a new drug quiet the ringing and dizziness of Meniere's disease?
Symptom relief CompletedThis study tests an experimental drug called SPI-1005 (ebselen) in adults with Meniere's disease, a condition that causes vertigo, tinnitus, and hearing loss. The trial compares three doses of SPI-1005 against a placebo to see if it safely reduces these symptoms. Researchers will…
Phase: PHASE1, PHASE2 • Sponsor: Sound Pharmaceuticals, Incorporated • Aim: Symptom relief
Last updated Jul 01, 2026 00:00 UTC
-
Which stitch is faster and safer for gastric bypass?
Symptom relief CompletedThis study compares two types of stitches used during robotic gastric bypass surgery for weight loss. About 150 adults with severe obesity will be randomly assigned to receive either a special barbed suture or a standard one. The main goal is to see which stitch is faster to use …
Sponsor: Aesculap AG • Aim: Symptom relief
Last updated Jul 01, 2026 00:00 UTC
-
Can a smartphone app curb binge eating? new study aims to find out.
Symptom relief CompletedThis study is testing a mobile app that gives weekly suggestions to help people with binge eating and obesity. The goal is to see which suggestions work best and in what order. About 300 adults who binge eat regularly and have a BMI of 30 or higher are taking part. The app tracks…
Phase: NA • Sponsor: Northwestern University • Aim: Symptom relief
Last updated Jul 01, 2026 00:00 UTC
-
Parkinson's patients: could a home workout sharpen your mind?
Symptom relief CompletedThis study tests whether a home-based, virtually-supervised exercise program combining high-intensity endurance and resistance training is safe and feasible for people with Parkinson's disease. It also looks at how exercise affects thinking skills and related biological markers. …
Phase: NA • Sponsor: University of California, San Francisco • Aim: Symptom relief
Last updated Jul 01, 2026 00:00 UTC
-
3D-Guided heat therapy targets enlarged prostate without cutting
Symptom relief CompletedThis pilot study tests a new way to treat urinary symptoms caused by an enlarged prostate. Using 3D ultrasound guidance, doctors insert a thin needle through the skin between the scrotum and anus to deliver microwave heat directly to the overgrown prostate tissue. The approach ai…
Phase: NA • Sponsor: Chinese University of Hong Kong • Aim: Symptom relief
Last updated Jun 27, 2026 14:03 UTC
-
Virtual reality showdown: which type of VR helps Parkinson's patients walk and think better?
Symptom relief CompletedThis pilot study compares two types of virtual reality (VR) rehabilitation for people with Parkinson's disease: immersive VR using a headset and non-immersive VR using a tablet. The goal is to see which approach better improves walking, balance, and thinking skills. Sixteen parti…
Phase: NA • Sponsor: Neuro Group XR Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 14:03 UTC
-
Cartoon calm: animated film may ease Kids' surgery fears
Symptom relief CompletedThis trial investigates whether a double-reading animated film, watched by both children and their parents before surgery, can reduce anxiety in children aged 3 to 7. The film uses avatars to walk the child through their hospital journey, from room to operating room. Researchers …
Phase: NA • Sponsor: University Hospital, Bordeaux • Aim: Symptom relief
Last updated Jun 27, 2026 14:02 UTC
-
Beetroot jelly could give swimmers a natural edge
Symptom relief CompletedThis study investigates whether a beetroot powder jelly candy can help competitive swimmers swim faster and feel less tired. Beetroot is rich in nitrate, which the body converts to nitric oxide, a compound that may improve blood flow and muscle efficiency. The trial involves 21 s…
Phase: NA • Sponsor: Halic University • Aim: Symptom relief
Last updated Jun 27, 2026 14:02 UTC
-
Could an amino acid shorten sickle cell pain crises?
Symptom relief CompletedThis phase 3 trial tests whether intravenous arginine, an amino acid, can shorten painful episodes in children with sickle cell disease. Participants aged 3 to 21 receive either arginine or a placebo alongside standard pain treatment. The study measures how quickly the crisis res…
Phase: PHASE3 • Sponsor: Claudia R. Morris • Aim: Symptom relief
Last updated Jun 27, 2026 14:02 UTC
-
Spinal zap showdown: which pattern best helps Parkinson's patients walk?
Symptom relief CompletedThis trial compares four different spinal cord stimulation settings to see which one best improves walking and balance in people with Parkinson's disease. Eleven participants who already have a spinal cord stimulator will try each setting in a random order. The study measures cha…
Phase: NA • Sponsor: University of Aarhus • Aim: Symptom relief
Last updated Jun 27, 2026 14:01 UTC
-
Virtual reality nature scenes tested as a calming tool before heart angiography
Symptom relief CompletedThis study tests whether watching virtual reality videos of mountains, beaches, and waterfalls before coronary angiography can lower anxiety, boost comfort, and improve patient satisfaction. Researchers will compare first-time angiography patients who use VR goggles to those who …
Phase: NA • Sponsor: TC Erciyes University • Aim: Symptom relief
Last updated Jun 27, 2026 14:01 UTC
-
What drives cancer patients to exercise? new study investigates
Knowledge-focused CompletedThis study looked at 422 breast cancer patients to understand what influences their beliefs about physical activity and their desire to be active. Researchers measured patients' knowledge of exercise benefits, their current activity levels, and fatigue. The goal was to learn how …
Phase: NA • Sponsor: Centre Antoine Lacassagne • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
Brain study sheds light on Parkinson's and tics
Knowledge-focused CompletedThis completed study from the National Institute of Neurological Disorders and Stroke aimed to better understand how the brain controls movement and what goes wrong in movement disorders like Parkinson's disease, Tourette's syndrome, and dystonia. Over 1,200 adults—both patients …
Phase: NA • Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
Scientists hunt for genes behind inner ear malformation
Knowledge-focused CompletedThis study looked at 324 people with hearing loss and an inner ear problem called enlarged vestibular aqueducts. Researchers collected DNA, hearing tests, and scans to find genes that may cause the condition. The goal was to learn more about why it happens, not to test a treatmen…
Sponsor: National Institute on Deafness and Other Communication Disorders (NIDCD) • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
Stretchy skin may reveal heart risks in rare genetic condition
Knowledge-focused CompletedThis study looked at how stretchy the skin and blood vessels are in people with Williams syndrome, a genetic condition that can cause heart problems. Researchers measured skin and pulse speed in 43 participants aged 5 to 70. The goal was to learn how these tissues change over tim…
Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
Scientists probe why obese people may handle thirst differently
Knowledge-focused CompletedThis completed study looked at how lean and obese individuals respond to thirst and water deprivation. Researchers gave 75 healthy men a high-salt infusion and a 24-hour water fast, measuring their thirst, hormone levels, and water intake. The goal was to understand if body fat a…
Phase: NA • Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
PET scans reveal how the brain thinks in health and disease
Knowledge-focused CompletedThis study used PET scans to measure blood flow in the frontal lobe while participants performed thinking tasks. It included healthy volunteers and people with schizophrenia or Parkinson's disease. The goal was to understand how the frontal lobe works during cognitive activities …
Sponsor: National Institute of Mental Health (NIMH) • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
Scientists probe why lung disease raises COVID-19 risk
Knowledge-focused CompletedThis study investigates how the immune system responds to COVID-19 in people with chronic lung conditions like asthma, COPD, or cystic fibrosis, compared to those without lung disease. Researchers collect blood, sputum, and nasal samples to measure immune signals and gene activit…
Sponsor: Imperial College London • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
Rare cholesterol disease study aims to detect heart risks early
Knowledge-focused CompletedThis study looks at people with a rare inherited condition that causes extremely high cholesterol and early heart disease. Researchers used special tests to measure artery hardening before it becomes life-threatening. The goal was to gather information to help develop future trea…
Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
No-Radiation 3D imaging tested for scoliosis and obesity
Knowledge-focused CompletedThis completed study used a 3D camera system called stereophotogrammetry to take pictures of the torso in healthy volunteers and people with scoliosis, chest wall deformities, or obesity. The goal was to refine the imaging technique, not to test a treatment. About 199 participant…
Sponsor: National Institutes of Health Clinical Center (CC) • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
Scientists unravel mysteries of puberty and fertility hormone
Knowledge-focused CompletedThis study looked at people with low or no GnRH, a hormone that controls puberty and fertility. Researchers studied 111 adults and teens to understand how GnRH problems affect the body. The goal was to find new hormone patterns and genetic causes, not to test a treatment.
Sponsor: National Institute of Environmental Health Sciences (NIEHS) • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
Chemotherapy's hidden heart toll: study probes lasting damage in breast cancer survivors
Knowledge-focused CompletedThis observational study looks at how anthracycline chemotherapy affects inflammation, oxidative stress, and heart function in adult women who had breast cancer. Researchers measure blood markers and use echocardiograms to assess heart changes about 10 years after treatment. The …
Sponsor: University of Chile • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
PET-CT scans could sharpen radiation targeting for liver tumors
Knowledge-focused CompletedThis study investigates whether PET-CT scans can accurately measure the radiation dose delivered by radioactive spheres during a liver cancer treatment called radioembolization. Researchers will compare scans taken before and after the procedure in patients with liver tumors. The…
Phase: NA • Sponsor: Fox Chase Cancer Center • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
New Light-Based device could spot troubled skin flaps after breast surgery
Knowledge-focused CompletedThis pilot study tests a near-infrared (NIR) imaging device that measures oxygen levels in breast skin flaps during and after mastectomy with immediate reconstruction. The goal is to see if the device can reliably detect areas with poor blood flow that might lead to healing probl…
Phase: NA • Sponsor: National Research Council, Institute of Clinical Physiology, Italy • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
Major study compares transplant vs. standard care for rare immune disease
Knowledge-focused CompletedThis study looked at 137 people with Chronic Granulomatous Disease (CGD), a rare immune disorder. It compared those who received a stem cell transplant with those who got standard care. The goal was to see which patients benefit most from transplant and what type of transplant wo…
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
Eye surgery aftermath: new tool measures corneal strength changes
Knowledge-focused CompletedThis study measured how three common eye surgeries—LASIK, PRK, and corneal cross-linking (CXL)—change the stiffness of the cornea. Using a device called Corvis ST, researchers assessed 150 adults who had undergone one of these procedures at least a month earlier. The goal was to …
Sponsor: Beni-Suef University • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
Rabies vaccine study seeks to sharpen prevention strategies
Knowledge-focused CompletedThis completed early-phase study looked at how healthy adults respond to the rabies vaccine when given alone or with an immune-boosting shot (rabies immune globulin). Thirty participants received different combinations of vaccine and immune globulin to compare antibody levels ove…
Phase: EARLY_PHASE1 • Sponsor: Washington University School of Medicine • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
Twin study seeks clues to rheumatic disease mysteries
Knowledge-focused CompletedThis study looks at families where one sibling has a rheumatic disease (like rheumatoid arthritis or lupus) and the other does not. Researchers compare their blood, genes, and environmental exposures to find clues about why one got sick. Over 1,000 participants are involved, incl…
Sponsor: National Institute of Environmental Health Sciences (NIEHS) • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
Family secrets? study maps how relatives talk about genetic health risks
Knowledge-focused CompletedThis study explored how family members share health information about genetic diseases like sickle cell, diabetes, and cancer. Over 1,000 adults completed surveys or interviews about their family health history and support. The goal was to understand social and relational factors…
Sponsor: National Human Genome Research Institute (NHGRI) • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
New study measures how brain radiation affects thinking and daily life
Knowledge-focused CompletedThis study looked at whether standard radiation treatment for cancer that has spread to the brain causes changes in thinking skills like memory and attention. 35 adults with brain metastases received radiation and took tests and surveys before and after treatment. The goal was to…
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
New study aims to personalize septic shock treatment with biomarkers
Knowledge-focused CompletedThis completed pilot study tested whether two biomarkers (renin and DPP3) can predict how well patients with septic shock respond to angiotensin II, a drug that raises blood pressure. Forty adults with persistent low blood pressure despite standard treatment were randomly assigne…
Phase: PHASE4 • Sponsor: University of New Mexico • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
PET scans may reveal hidden leukemia spots before CAR t treatment
Knowledge-focused CompletedThis pilot study tested whether PET-CT scans can detect leukemia that has spread outside the bone marrow in patients with relapsed or hard-to-treat B-cell acute lymphoblastic leukemia (ALL). Ten participants received a PET scan before and after CAR T-cell therapy. The goal was to…
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
Default option nudge may boost cancer screening in High-Risk groups
Knowledge-focused CompletedThis trial tests whether presenting a cancer screening appointment as a pre-selected default option (opt-out) makes people at high risk for lung or stomach cancer more likely to accept it, compared to a standard opt-in approach. Participants complete an online questionnaire and d…
Phase: NA • Sponsor: Harbin Medical University • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
Can scans replace breathing tests to monitor lung scarring?
Knowledge-focused CompletedThis study follows 31 people with progressive fibrosing interstitial lung disease (PF-ILD) for one year. Researchers compare imaging scans (CT and MRI) with standard breathing tests to see which method best tracks lung damage over time. The goal is to find better ways to measure …
Phase: NA • Sponsor: Boehringer Ingelheim • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
Skin biopsies may reveal long COVID's hidden nerve damage
Knowledge-focused CompletedThis study looks at tiny nerve fibers in the skin of people with Long COVID, POTS, diabetic neuropathy, and those who had COVID-19 without lasting symptoms. By comparing skin samples, researchers hope to find unique patterns that help explain ongoing symptoms like pain and dizzin…
Sponsor: CND Life Sciences • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
Scientists dive into rare cholesterol disorders to uncover clues
Knowledge-focused CompletedThis study looks at rare genetic disorders where the body can't make cholesterol properly, which can cause birth defects and learning problems. Researchers collect blood, urine, and tissue samples from affected people and their families to learn more about these conditions. The g…
Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
Decade-Long study aims to unlock liver disease risks in HIV-Hepatitis b patients
Knowledge-focused CompletedThis study follows adults in Zambia who have both HIV and chronic hepatitis B to track liver health over up to 10 years. Researchers aim to understand how current HIV treatments affect hepatitis B and liver damage, and to identify factors that lead to serious outcomes like liver …
Sponsor: University of Alabama at Birmingham • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
Researchers observe bone disorders to expand knowledge
Knowledge-focused CompletedThis study looked at people with suspected bone-related connective tissue disorders (like brittle bone disease) and their healthy family members. The goal was to learn more about these conditions, train doctors, and collect samples for future research. Participants received stand…
Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
Large study digs into rare brain tumors to uncover clues
Knowledge-focused CompletedThis study gathered information from 326 adults with rare central nervous system tumors, such as medulloblastoma and ependymoma. Participants completed surveys about their symptoms, treatments, and lifestyle, and provided a saliva sample for genetic analysis. The goal was to lear…
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
Scientists probe the mystery of dense breasts and cancer
Knowledge-focused CompletedThis study looked at why some women have dense breasts on mammograms and why that increases their risk of breast cancer. Researchers collected tissue samples, medical records, and health updates from 466 women aged 40-65 who were having a breast biopsy. The goal was to understand…
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
New registry tracks pregnancy in women with rare metabolic diseases
Knowledge-focused CompletedThis study created a registry of medical records from women with inborn errors of metabolism—rare conditions that affect how the body turns food into energy. Researchers collected data from past or current pregnancies and followed babies for one year after birth. The goal was to …
Sponsor: National Human Genome Research Institute (NHGRI) • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
Scientists probe Drug-Induced sunburn reactions
Knowledge-focused CompletedThis study looks at why some medications, like the antifungal voriconazole, can cause extreme sensitivity to sunlight, leading to severe sunburn-like reactions. Researchers will measure gene activity in skin samples from 62 participants, including healthy volunteers and patients …
Phase: PHASE1 • Sponsor: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
Scientists uncover genetic secrets behind rare hormone disorders
Knowledge-focused CompletedThis study looked at nearly 1,400 people with rare conditions like PPNAD, Carney Complex, and Peutz-Jeghers syndrome. The goal was to find the genetic causes and link them to specific symptoms. Researchers used clinical exams and genetic testing to better understand how these dis…
Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
Scientists track skin tumors in NF1 to uncover clues for future therapies
Knowledge-focused CompletedThis study followed 17 adults with neurofibromatosis type 1 (NF1) over two years to learn how their skin tumors (dermal neurofibromas) grow and change. Researchers used special cameras and skin biopsies to measure tumor growth and look for genes that might influence it. The goal …
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
NIH launches study to unravel mysteries of rare genetic brain disease CADASIL
Knowledge-focused CompletedThis study looked at 20 people with CADASIL, a rare genetic disease that damages brain arteries and causes migraines, strokes, and dementia. Researchers used blood tests, skin biopsies, eye exams, and brain scans to learn more about how the disease works. The goal was to better u…
Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
Scientists track severe allergies to uncover hidden patterns
Knowledge-focused CompletedThis completed study followed 945 people, mostly children and young adults with severe eczema or related allergic conditions, along with their relatives. Researchers observed how these diseases progress over up to a year, using tests like allergy skin pricks, blood draws, and lun…
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
AI chatbot aims to boost HIV testing among malaysian men
Knowledge-focused CompletedThis study is testing whether an AI-powered chatbot on a smartphone can encourage more men in Malaysia to get tested for HIV. The study will enroll 296 men who have sex with men and have not been tested recently. Participants will use the chatbot and report every 30 days whether …
Phase: NA • Sponsor: Yale University • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
Scientists investigate why adrenal tumors produce hormones
Knowledge-focused CompletedThis study looked at adrenal gland tumors to understand why they form, why some release extra hormones, and why some are cancerous. Researchers studied 690 people with known or suspected adrenal tumors. Participants underwent tests like blood draws, imaging scans, and urine colle…
Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
New brain scans aim to unlock Parkinson's mysteries
Knowledge-focused CompletedThis study used brain imaging to understand how Parkinson's disease changes the brain over time. Researchers compared people with definite or possible Parkinson's to healthy volunteers. Participants had up to six visits over nine years, including MRI scans and symptom checks. The…
Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
Cooking up health: new study tests if free produce and lessons help cancer survivors
Knowledge-focused CompletedThis study looks at whether a 12-week program of cooking demonstrations, recipe cards, and free fruit and vegetable bundles can help cancer survivors eat healthier. Only 11 people are taking part, and the main goal is to see if such a program is practical and keeps people interes…
Phase: NA • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
Scientists hunt for hidden causes of painful leg ulcers in sickle cell disease
Knowledge-focused CompletedThis completed study looked at why people with sickle cell disease develop chronic leg ulcers. Researchers collected skin swabs, blood samples, and survey data from 405 adults to explore the role of skin bacteria and environmental factors. The goal was to better understand the ca…
Sponsor: National Human Genome Research Institute (NHGRI) • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
NIH scientists probe immune secrets behind flu vaccines
Knowledge-focused CompletedThis study aimed to understand how the immune system responds to seasonal and H1N1 flu vaccines in healthy adults. Researchers collected blood and nasal samples from 203 NIH employees before and after vaccination. The goal was to analyze immune responses to improve future vaccine…
Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
Psoriasis study probes hidden heart risks
Knowledge-focused CompletedThis completed study looked at 386 adults with psoriasis to understand how skin inflammation might be linked to heart and blood vessel diseases. Participants had up to seven visits over four years, including blood tests, heart scans, and optional skin biopsies. The goal was to se…
Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
Tiny study probes how radiation wakes up immune cells in lung tumors
Knowledge-focused CompletedThis pilot study looked at how radiation therapy changes immune cells inside stage I lung cancer tumors. Researchers took biopsies before and after radiation to track T-cell changes and identify tumor antigens. Only 6 people took part, so the goal was to gather early data, not to…
Phase: NA • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
Small study aims to unlock secrets of rare lung disease
Knowledge-focused CompletedThis completed Phase 1 study looked at 27 people with and without pulmonary hypertension to learn more about how blood vessel problems contribute to the disease. Researchers used heart catheterization, imaging, and blood tests to find biomarkers and understand disease mechanisms.…
Phase: PHASE1 • Sponsor: National Institutes of Health Clinical Center (CC) • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
Could an eye exam reveal hidden brain damage in HIV patients?
Knowledge-focused CompletedThis study looks at cerebral small vessel disease (CSVD) — damage to tiny blood vessels in the brain that can cause memory loss and disability — in people with HIV over age 50. Researchers want to see if CSVD is linked to blood vessel problems in the eyes and kidneys, which could…
Sponsor: Fondation Ophtalmologique Adolphe de Rothschild • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
Rare genetic disorder studied for clues to better care
Knowledge-focused CompletedThis study looked at Smith-Lemli-Opitz syndrome (SLOS), a rare genetic condition that affects cholesterol production and causes birth defects and intellectual disabilities. Researchers enrolled 130 patients and their mothers to learn more about the disease's progression, genetic …
Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
Gene hunt for rare cholesterol problems
Knowledge-focused CompletedThis study aimed to find new gene changes that cause rare lipid disorders. Researchers used advanced genetic testing to look at many genes at once in 140 people and their relatives. The goal was to discover causes that older methods missed.
Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
French study tracks COVID-19's toll on pregnant women and their babies
Knowledge-focused CompletedThis study follows thousands of pregnant women in France who had or likely had COVID-19 during pregnancy or shortly after giving birth. Researchers track health problems in both mothers and newborns up to 12 weeks after delivery, using medical records and questionnaires about men…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jul 03, 2026 00:00 UTC
-
ER pharmacists tackle dementia medication risks
Knowledge-focused CompletedThis study looked at whether emergency department pharmacists can safely reduce the use of certain brain-active medications in people with dementia or mild cognitive impairment. Researchers worked with 300 participants to see if pharmacists could communicate medication changes to…
Phase: NA • Sponsor: National Institute on Aging (NIA) • Aim: Knowledge-focused
Last updated Jul 03, 2026 00:00 UTC
-
What makes skin cancer patients happy after surgery?
Knowledge-focused CompletedThis study looks at how satisfied people are after having skin cancer surgery. Researchers ask patients to rate their experience with the surgeon, the facility, the procedure itself, and their recovery. The goal is to understand what matters most to patients and find ways to impr…
Sponsor: Northwestern University • Aim: Knowledge-focused
Last updated Jul 03, 2026 00:00 UTC
-
New freezing biopsy could make lung cancer diagnosis safer
Knowledge-focused CompletedThis study tests whether a biopsy technique called transbronchial cryobiopsy is safer than the standard method for diagnosing lung cancer. About 100 adults with known or suspected lung cancer will undergo the procedure under general anesthesia. Researchers will track complication…
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Knowledge-focused
Last updated Jul 03, 2026 00:00 UTC
-
Brain training for anxious kids: a 45-minute computer session may alter error responses
Knowledge-focused CompletedThis study looks at how the brains of children aged 9 to 12 with anxiety disorders respond to making mistakes. Researchers measure two types of brain activity: one after an error and one after a balance disturbance. Half of the children will use a 45-minute computer program desig…
Phase: NA • Sponsor: Florida State University • Aim: Knowledge-focused
Last updated Jul 03, 2026 00:00 UTC
-
Hidden thyroid cancers: how common are they in patients with thyroiditis?
Knowledge-focused CompletedThis completed study from Minia University looked at 200 patients with autoimmune thyroiditis (an inflamed thyroid) who had thyroid surgery. The goal was to see how often thyroid cancer is found by accident when examining the removed tissue. Researchers checked for cancer in pati…
Phase: NA • Sponsor: Minia University • Aim: Knowledge-focused
Last updated Jul 03, 2026 00:00 UTC
-
Could lower eye pressure during cataract surgery reduce corneal damage?
Knowledge-focused CompletedThis study investigates whether using a lower, more natural eye pressure during cataract surgery reduces trauma to the cornea compared to traditional high-pressure methods. The Active Sentry device helps maintain stable pressure by sensing changes in the eye. Researchers will mea…
Phase: NA • Sponsor: Centre hospitalier de l'Université de Montréal (CHUM) • Aim: Knowledge-focused
Last updated Jul 03, 2026 00:00 UTC
-
Can a quick Warm-Up boost your jump? infrared and massage put to the test
Knowledge-focused CompletedThis study compares two passive warm-up methods—infrared heating and therapeutic massage—to see which one improves balance and jump performance better. One hundred healthy adults aged 18-35 will do a short cycling warm-up followed by either infrared or massage, then be tested on …
Phase: NA • Sponsor: Istanbul University - Cerrahpasa • Aim: Knowledge-focused
Last updated Jul 03, 2026 00:00 UTC
-
Grip strength may predict cancer patient survival
Knowledge-focused CompletedThis completed study looked at 130 hospitalized cancer patients to see if hand grip strength could predict short-term outcomes like death within 30 days, ICU admission, or hospital readmission. Researchers measured grip strength within 24 hours of admission using a simple, non-in…
Sponsor: Ankara Etlik City Hospital • Aim: Knowledge-focused
Last updated Jul 03, 2026 00:00 UTC
-
Suction or no suction? lung biopsy study seeks better samples
Knowledge-focused CompletedThis study looks at whether using suction during a lung biopsy (EBUS-TBNA) helps get better tissue samples from people with suspected lung cancer that has spread to lymph nodes. Researchers will compare samples taken with and without suction to see which method gives more materia…
Phase: NA • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Knowledge-focused
Last updated Jul 03, 2026 00:00 UTC
-
New oxygen sensor could give earlier warning for elderly and obese patients under anesthesia
Knowledge-focused CompletedThis study tests whether a device called the oxygen reserve index (ORi) can warn doctors earlier than standard pulse oximetry when an older patient's oxygen level starts to drop during surgery. Researchers are comparing obese and non-obese patients aged 65 and older to see if ORi…
Sponsor: Ankara City Hospital Bilkent • Aim: Knowledge-focused
Last updated Jul 03, 2026 00:00 UTC
-
Could breast cancer survivors face higher colon cancer risk?
Knowledge-focused CompletedThis study investigates whether women who have completed breast cancer treatment have a higher chance of developing colorectal polyps or colon cancer. Researchers will perform screening colonoscopies in 216 asymptomatic breast cancer survivors and check for abnormal growths. The …
Phase: NA • Sponsor: Haydarpasa Numune Training and Research Hospital • Aim: Knowledge-focused
Last updated Jul 03, 2026 00:00 UTC
-
Brain scans reveal how language therapy rewires Stroke-Damaged brains
Knowledge-focused CompletedThis study investigates how different language treatments affect both language skills and brain function in people with aphasia, a condition that impairs the ability to speak, understand, read, or write after a stroke. Participants will receive therapy targeting naming, spelling,…
Phase: NA • Sponsor: Northwestern University • Aim: Knowledge-focused
Last updated Jul 03, 2026 00:00 UTC
-
Breath sniffing may reveal early clues to cystic fibrosis drug success
Knowledge-focused CompletedThis study explores whether analyzing the chemicals in exhaled breath can detect early changes in children with cystic fibrosis who start taking a medication called Kaftrio. Researchers will collect breath samples from 50 children under 12 before and after they begin treatment, l…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jul 03, 2026 00:00 UTC
-
Can a simple referral program reduce COVID-19 health gaps?
Knowledge-focused CompletedThis study tests a program called SINCERE that screens people for social needs like food or housing help, then connects them to free community services with follow-up calls. Researchers want to see if this improves overall health, depression, and anxiety in 1500 adults at risk fo…
Phase: NA • Sponsor: Andrea Wallace • Aim: Knowledge-focused
Last updated Jul 03, 2026 00:00 UTC
-
One-year survival and recovery in elderly COVID-19 patients under scrutiny
Knowledge-focused CompletedThis study follows people aged 70 and older who were hospitalized with severe COVID-19 for one year after their diagnosis. Researchers aim to describe how many survive and how well they recover, including physical and mental function. The goal is to better understand the long-ter…
Sponsor: Centre Hospitalier le Mans • Aim: Knowledge-focused
Last updated Jul 03, 2026 00:00 UTC
-
Radiation safety study aims to personalize thyroid cancer treatment
Knowledge-focused CompletedThis study collects standard-of-care images from people with differentiated thyroid cancer who are treated with radioactive iodine (Iodine-131). The goal is to better understand how much radiation reaches healthy organs and what dose is needed to destroy thyroid tissue. By gather…
Sponsor: Institut Claudius Regaud • Aim: Knowledge-focused
Last updated Jul 03, 2026 00:00 UTC
-
Simple grip device could help track muscle strength in scoliosis
Knowledge-focused CompletedThis study investigates whether a portable, affordable hand dynamometer can reliably measure trunk muscle strength in adolescents with idiopathic scoliosis. Researchers will test the device on 41 teens aged 10-18, comparing results between two evaluators and across two sessions o…
Sponsor: Istanbul University - Cerrahpasa • Aim: Knowledge-focused
Last updated Jul 03, 2026 00:00 UTC
-
Hidden danger: study probes blood clot risk in cancer patients with COVID-19
Knowledge-focused CompletedThis study investigates how often cancer patients with COVID-19 develop dangerous blood clots (venous thromboembolism). Researchers will screen participants using ultrasound and blood tests to detect clots, whether or not they cause symptoms. The goal is to understand the true ra…
Phase: NA • Sponsor: Centre Antoine Lacassagne • Aim: Knowledge-focused
Last updated Jul 03, 2026 00:00 UTC
-
Tracking superbugs from mother to baby: a chicago study
Knowledge-focused CompletedThis study looks at how drug-resistant bacteria, specifically ESBL-producing E. coli, are passed from mothers to their newborns during vaginal birth or scheduled C-sections. Researchers will test stool samples from 200 healthy mothers and their babies at a Chicago hospital to see…
Sponsor: Ann & Robert H Lurie Children's Hospital of Chicago • Aim: Knowledge-focused
Last updated Jul 03, 2026 00:00 UTC
-
New tool aims to boost lung cancer trial enrollment
Knowledge-focused CompletedThis study develops and tests a tool designed to help lung cancer nurses talk to patients about clinical trials. The tool provides information on available trials, communication tips, and practical guidance. Researchers will test it in four UK hospitals to see if it improves nurs…
Sponsor: Oxford Brookes University • Aim: Knowledge-focused
Last updated Jul 03, 2026 00:00 UTC
-
Scientists investigate relapse after CAR t: blood draws hold clues
Knowledge-focused CompletedThis study tracks 50 people with blood cancers who are receiving CAR T therapy. Researchers will take blood samples over time to measure immune cells and genetic changes. The goal is to find patterns that predict or explain why the cancer comes back. This is an observational stud…
Sponsor: Duke University • Aim: Knowledge-focused
Last updated Jul 03, 2026 00:00 UTC
-
Rare botulism cases reviewed to improve ICU care
Knowledge-focused CompletedThis study reviews the medical records of people who were hospitalized in French intensive care units (ICUs) for severe botulism poisoning. Botulism is a rare but serious illness caused by a toxin that can paralyze muscles. The goal is to describe what happened to these patients,…
Sponsor: Centre Hospitalier le Mans • Aim: Knowledge-focused
Last updated Jul 03, 2026 00:00 UTC
-
Can a short video boost cancer trial enrollment in rural communities?
Knowledge-focused CompletedThis study explores whether an online educational video can help people living in rural parts of New Hampshire and Vermont learn about cancer research and clinical trials. Researchers will measure changes in knowledge, attitudes, and actual enrollment in cancer studies over six m…
Phase: NA • Sponsor: Dartmouth-Hitchcock Medical Center • Aim: Knowledge-focused
Last updated Jul 02, 2026 00:00 UTC
-
Acne Drug's hidden toll on the eye revealed
Knowledge-focused CompletedThis study looks at how isotretinoin, a vitamin A-based acne medication, affects eye structures and tear production in people with severe cystic acne. Participants receive standard treatment and undergo eye exams, including dry eye tests and advanced imaging, before and during th…
Phase: NA • Sponsor: Demet Mutlu • Aim: Knowledge-focused
Last updated Jul 02, 2026 00:00 UTC
-
Liberia's HIV epidemic under the microscope: major study completed
Knowledge-focused CompletedThis study followed 1,377 people living with HIV in Liberia over three years to track how the disease progresses and affects their health. Researchers collected blood and urine samples, conducted physical exams, and asked about medications and risk behaviors. The goal was to gath…
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated Jul 02, 2026 00:00 UTC
-
Can we predict dangerous blood clots in lymphoma patients? a major study aims to find out
Knowledge-focused CompletedThis study looks at how well existing risk models predict dangerous blood clots in people with diffuse large B-cell lymphoma (DLBCL), a common type of blood cancer. Researchers will review medical records from over 1,500 patients across multiple hospitals to see which factors are…
Sponsor: Fondazione IRCCS San Gerardo dei Tintori • Aim: Knowledge-focused
Last updated Jul 02, 2026 00:00 UTC
-
Scientists investigate why some people resist weight gain
Knowledge-focused CompletedThis study looked at how the body's metabolism changes when people overeat or fast, and how different diets (like high-protein or high-fat) affect those changes. About 200 healthy adults aged 18-55 participated. The goal was to understand why some people are more resistant to gai…
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Knowledge-focused
Last updated Jul 02, 2026 00:00 UTC
-
Liver function may predict dangerous side effect in common breast cancer drug
Knowledge-focused CompletedThis study looks at whether breast cancer patients with mild, moderate, or severe liver problems face a higher risk of a serious side effect—grade 4 neutropenia (a dangerous drop in infection-fighting white blood cells)—when taking the drug palbociclib. Researchers analyzed medic…
Sponsor: Pfizer • Aim: Knowledge-focused
Last updated Jul 02, 2026 00:00 UTC
-
Scientists map protein patterns in lymphoma to unlock disease secrets
Knowledge-focused CompletedThis completed study analyzed leftover tissue samples from 130 people with lymphoma or related conditions. Researchers measured levels of histone and other proteins to find patterns linked to different lymphoma types. The goal was to better understand the biology of these cancers…
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Jul 02, 2026 00:00 UTC
-
New training aims to help people in legal diversion handle crises
Knowledge-focused CompletedThis pilot study tested a training called Crisis Ready for people in a Baltimore diversion program. The training teaches how to use a crisis hotline and how to give naloxone to reverse an overdose. Researchers wanted to see if participants found the training likable and useful. O…
Phase: NA • Sponsor: RAND • Aim: Knowledge-focused
Last updated Jul 02, 2026 00:00 UTC
-
Podcast vs. pamphlet: which boosts IBD knowledge best?
Knowledge-focused CompletedThis study compares two simple educational tools—a written PDF and an audio podcast—to see which helps people with inflammatory bowel disease (IBD) learn more about their condition. Participants fill out questionnaires at the start and after three months to measure knowledge, sat…
Phase: NA • Sponsor: Szeged University • Aim: Knowledge-focused
Last updated Jul 02, 2026 00:00 UTC
-
Study maps out tumor detection in rare stomach condition
Knowledge-focused CompletedThis completed study looked at how to best find and manage tumors in people with Zollinger-Ellison syndrome, a rare condition that causes too much stomach acid. Researchers used imaging tests and tissue samples to locate tumors and check for a related genetic condition called MEN…
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Knowledge-focused
Last updated Jul 02, 2026 00:00 UTC
-
Tape measure may spot hidden heart attack danger
Knowledge-focused CompletedThis study looks at whether the neck-to-waist ratio can help identify patients with high blood pressure and a specific type of heart attack. Researchers measured body shapes of 238 adults arriving at the emergency room with chest pain. The goal is to see if simple body measuremen…
Sponsor: Ercis Sehit Rıdvan Cevik State Hospital • Aim: Knowledge-focused
Last updated Jul 02, 2026 00:00 UTC
-
Scientists track dengue in kids to stop Mosquito-Borne illness
Knowledge-focused CompletedThis study followed 775 healthy children aged 2-9 in Cambodia over three years to learn how mosquitoes spread dengue and other viruses. Researchers took blood samples every wet and dry season to check for past or current infections. The goal was to understand why young children g…
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated Jul 02, 2026 00:00 UTC
-
Tiny study hopes to unlock why pollution hurts some lungs more
Knowledge-focused CompletedThis completed study looked at how genetic differences might change the way immune cells in the lungs respond to environmental triggers like dust and germs. Researchers collected blood and lung samples from 20 healthy adults to compare cell function between people with different …
Sponsor: National Institute of Environmental Health Sciences (NIEHS) • Aim: Knowledge-focused
Last updated Jul 02, 2026 00:00 UTC
-
Eye disease study tracks vision loss over years
Knowledge-focused CompletedThis study followed 20 adults aged 55 and older with geographic atrophy, an advanced form of age-related macular degeneration that causes central vision loss. Researchers measured how the damaged area in the eye changed over nearly 4 years using eye exams and photos. The goal was…
Sponsor: National Eye Institute (NEI) • Aim: Knowledge-focused
Last updated Jul 02, 2026 00:00 UTC
-
Long-Term study aims to unlock secrets of brittle bone disease
Knowledge-focused CompletedThis study followed 88 children and young adults with types III and IV osteogenesis imperfecta (brittle bone disease) to track how the condition changes over time. Researchers measured bone density, lung and heart function, hearing, and movement abilities. The goal was to better …
Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) • Aim: Knowledge-focused
Last updated Jul 02, 2026 00:00 UTC
-
Tiny trial aims to perfect brain stimulation timing for Parkinson's
Knowledge-focused CompletedThis study tests a device that synchronizes two types of brain stimulation — deep brain stimulation (DBS) and transcranial alternating current stimulation (tACS) — in people with Parkinson's disease. Only 2 participants will be enrolled to see if the device can lock the timing of…
Phase: NA • Sponsor: Universitätsklinikum Hamburg-Eppendorf • Aim: Knowledge-focused
Last updated Jul 02, 2026 00:00 UTC
-
Study explores how family and friends impact caregiver health
Knowledge-focused CompletedThis completed study looked at how the social networks of caregivers affect their stress and health when caring for someone with an inherited disease. Researchers surveyed over 680 participants, including family members and formal caregivers, to understand caregiving burden and s…
Sponsor: National Human Genome Research Institute (NHGRI) • Aim: Knowledge-focused
Last updated Jul 02, 2026 00:00 UTC
-
New study asks: do transgender people know their gynaecological health risks?
Knowledge-focused CompletedThis study surveys 500 transgender adults in France to find out how much they know about gynaecological care and cancer screening. Participants fill out an online questionnaire. The goal is to understand gaps in knowledge and improve healthcare recommendations for this community.
Sponsor: University Hospital, Bordeaux • Aim: Knowledge-focused
Last updated Jul 02, 2026 00:00 UTC
-
Blood safety watch: 1,771 transfusion patients tracked for hidden infections
Knowledge-focused CompletedThis study followed 1,771 adults and children who received blood transfusions to check how safe the blood supply is. Researchers tested patients' blood for viruses like HIV and hepatitis before and after transfusion, and stored samples for future testing. The goal was to keep blo…
Sponsor: National Institutes of Health Clinical Center (CC) • Aim: Knowledge-focused
Last updated Jul 02, 2026 00:00 UTC
-
Fat tissue differences may explain why diabetes hits some ethnic groups harder
Knowledge-focused CompletedThis completed pilot study examined how fat tissue dysfunction contributes to type 2 diabetes risk in overweight men from South Asian, Black African/Caribbean, and White European backgrounds. Researchers used MRI scans and blood tests to measure fat distribution, inflammation, an…
Sponsor: University of Roehampton • Aim: Knowledge-focused
Last updated Jul 02, 2026 00:00 UTC
-
Fizzy drink study probes saliva secrets
Knowledge-focused CompletedThis study investigates how flavored carbonated drinks change saliva flow, composition, and taste perception compared to plain water, carbonated water, or non-carbonated drinks. Healthy adults aged 18-45 who regularly drink carbonated beverages will provide saliva samples after t…
Phase: NA • Sponsor: PepsiCo Global R&D • Aim: Knowledge-focused
Last updated Jul 02, 2026 00:00 UTC
-
Scientists compare sputum collection methods to improve diagnosis of lung infection
Knowledge-focused CompletedThis study looked at different ways to collect sputum (phlegm) from people with a lung infection called nontuberculous mycobacterial (NTM) infection. The goal was to see which method gives the best samples for diagnosing and understanding the infection. Participants provided thro…
Sponsor: National Institutes of Health Clinical Center (CC) • Aim: Knowledge-focused
Last updated Jul 02, 2026 00:00 UTC
-
Fatty liver mystery: could how we process food be the key?
Knowledge-focused CompletedThis study looked at how people with and without non-alcoholic fatty liver disease (NAFLD) process food. Researchers monitored 53 adults over two days, measuring metabolism, blood, and urine after meals. The goal was to find differences that might explain why fat builds up in the…
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Knowledge-focused
Last updated Jul 02, 2026 00:00 UTC
-
Could a cooler room help you burn more calories? scientists investigate.
Knowledge-focused CompletedThis study looked at how being in different temperatures (from about 61°F to 88°F) affects how many calories healthy adults burn. Researchers also checked for brown fat activity, a type of fat that burns energy to keep you warm. 104 healthy men and women stayed in a hospital unit…
Phase: NA • Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Knowledge-focused
Last updated Jul 02, 2026 00:00 UTC
-
New tool aims to boost lung cancer trial enrollment
Knowledge-focused CompletedThis study aims to develop and test a tool that helps lung cancer nurses talk to patients about clinical trials. Only about 8% of lung cancer patients in the UK join trials, and nurses often lack the time or confidence to discuss them. The tool will be tested in four UK hospitals…
Phase: NA • Sponsor: Oxford Brookes University • Aim: Knowledge-focused
Last updated Jul 02, 2026 00:00 UTC
-
Could your workout change the germs in your mouth?
Knowledge-focused CompletedThis study looks at how different amounts of endurance exercise—from none to high levels—affect the bacteria living in the mouth of young adults aged 18 to 30. Researchers will collect saliva and gum samples to compare the oral microbiome and signs of inflammation. The goal is to…
Phase: NA • Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Knowledge-focused
Last updated Jul 02, 2026 00:00 UTC
-
Can you train your body to handle pain better? new study investigates
Knowledge-focused CompletedThis study aims to understand why people experience pain differently and whether the body's natural ability to manage pain can be improved through training, similar to athletic performance. Researchers will enroll 180 adults, including those with widespread muscle pain and those …
Phase: NA • Sponsor: University of Florida • Aim: Knowledge-focused
Last updated Jul 02, 2026 00:00 UTC
-
Greek registry aims to map hidden genetic cholesterol disorder
Knowledge-focused CompletedThis study creates a registry for people with familial hypercholesterolemia (FH) in Greece, a genetic condition that causes very high cholesterol and early heart disease. Researchers will screen adults aged 18 to 80 to learn how common FH is and describe the health of those affec…
Sponsor: Hellenic College of Treatment of Atherosclerosis • Aim: Knowledge-focused
Last updated Jul 02, 2026 00:00 UTC
-
Lymphoma drug safety under the microscope in 1,000-Patient study
Knowledge-focused CompletedThis study follows 1,000 people with CD30-positive lymphoma who are already receiving or about to receive brentuximab vedotin as part of their normal care. Researchers will track side effects and how the drug is used in everyday practice, without giving any new treatment. The goa…
Sponsor: Takeda • Aim: Knowledge-focused
Last updated Jul 02, 2026 00:00 UTC
-
Protein 'Fingerprint' blood test could warn of ovarian cancer return
Knowledge-focused CompletedThis study looks at proteins in the blood of women with ovarian, peritoneal, or fallopian tube cancer who are in remission. The goal is to find a protein pattern, or 'fingerprint,' that signals when the cancer might come back. Researchers followed 119 women with stage III or IV c…
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Jul 02, 2026 00:00 UTC
-
Family talk could be key to preventing disease in Mexican-American communities
Knowledge-focused CompletedThis study examined how Mexican-American families discuss their risk for diabetes, heart disease, breast cancer, and colon cancer. Researchers interviewed 498 adults from Mexican-American households in Houston to understand how culture and family history influence health communic…
Sponsor: National Human Genome Research Institute (NHGRI) • Aim: Knowledge-focused
Last updated Jul 02, 2026 00:00 UTC
-
Real-world data may reveal true effectiveness of leading breast cancer therapy
Knowledge-focused CompletedThis study looks at medical records from across Europe to see how well a drug combination (palbociclib plus an aromatase inhibitor) works as a first treatment for people with a common type of advanced breast cancer (HR+/HER2-). Researchers want to understand how long the treatmen…
Sponsor: Pfizer • Aim: Knowledge-focused
Last updated Jul 02, 2026 00:00 UTC
-
Can a quick chat with a radiotherapy tech ease cancer patients' anxiety?
Knowledge-focused CompletedThis study looked at whether having a special consultation with a radiotherapy technician (called a manipulator) helps cancer patients feel more informed about their treatment. Researchers enrolled 308 adults with various cancers who were getting radiation therapy. They compared …
Phase: NA • Sponsor: Centre Antoine Lacassagne • Aim: Knowledge-focused
Last updated Jul 02, 2026 00:00 UTC
-
Night vision test could spot early eye disease
Knowledge-focused CompletedThis study looked at whether a simple test measuring how fast eyes recover in the dark can help track early to middle dry age-related macular degeneration (AMD). Researchers followed 217 adults aged 50 and older, with or without AMD, for up to 5 years. The goal was to see if chan…
Sponsor: National Eye Institute (NEI) • Aim: Knowledge-focused
Last updated Jul 02, 2026 00:00 UTC
-
New document helps young adults voice End-of-Life wishes
Knowledge-focused CompletedThis study tested a document called Voicing My CHOiCES, designed to help young adults (ages 18-39) with serious illnesses like cancer or HIV discuss their care preferences. Participants filled out questionnaires about anxiety, social support, and communication, then reviewed the …
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Jul 02, 2026 00:00 UTC
-
Can your diet calm your arthritis? new study investigates
Knowledge-focused CompletedThis study is looking at how nutrition affects disease activity in people with rheumatic diseases like rheumatoid arthritis, lupus, and psoriatic arthritis. Researchers will measure the nutritional status of 460 participants using several different tools and compare it to how act…
Sponsor: Cairo University • Aim: Knowledge-focused
Last updated Jul 02, 2026 00:00 UTC
-
Pfizer mines insurance data to see if its vaccine stops long COVID
Knowledge-focused CompletedThis study looks at anonymous health records from California and Louisiana to see if the Pfizer-BioNTech COVID-19 vaccine helps prevent post-COVID conditions (long COVID). Researchers will also track who gets vaccinated. The study includes adults with a COVID-19 diagnosis between…
Sponsor: Pfizer • Aim: Knowledge-focused
Last updated Jul 02, 2026 00:00 UTC
-
Graphene brain sensor tested in humans for first time
Knowledge-focused CompletedThis study tests a new graphene-based electrode array used during brain tumor surgery to map brain activity. Ten participants will have the device used alongside standard monitoring to check its safety and how well it records brain signals. If awake during surgery, they may do si…
Phase: NA • Sponsor: University of Manchester • Aim: Knowledge-focused
Last updated Jul 02, 2026 00:00 UTC
-
New drug Leucettinib-21 enters first human safety trials
Knowledge-focused CompletedThis study is the first time Leucettinib-21 is being tested in humans. It aims to check the drug's safety and how the body processes it. The trial includes healthy volunteers and people with Down syndrome or Alzheimer's disease. No treatment benefit is expected at this early stag…
Phase: PHASE1 • Sponsor: Perha Pharmaceuticals • Aim: Knowledge-focused
Last updated Jul 02, 2026 00:00 UTC
-
Tiny doses of atropine: unlocking the Eye's response to slow nearsightedness
Knowledge-focused CompletedThis study investigates how low doses of atropine eye drops (0.01%, 0.02%, and 0.05%) affect pupil size and the eye's ability to focus in healthy adults aged 18 to 40. Researchers aim to compare different dosing methods and recovery times, and to see if iris color influences the …
Phase: PHASE1 • Sponsor: University of California, Berkeley • Aim: Knowledge-focused
Last updated Jul 02, 2026 00:00 UTC
-
New scan and genetic tests aim to catch cancer early in NF1 patients
Knowledge-focused CompletedThis study looked at people with neurofibromatosis type 1 (NF1) to better understand how harmless tumors (plexiform neurofibromas) turn into a rare cancer called MPNST. Ten participants had MRI, PET scans, and tumor biopsies. Researchers tested whether a special PET scan (FLT PET…
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Jul 02, 2026 00:00 UTC
-
Which TB test works best for HIV patients? new study aims to find out
Knowledge-focused CompletedThis study looked at 200 people living with HIV in Liberia to compare two tests for latent tuberculosis (TB) infection: a blood test (IGRA) and a skin test (TST). The goal was to see which test works better in this population. Participants had a skin test and their results were c…
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated Jul 02, 2026 00:00 UTC
-
Radiation's hidden toll: study tracks tooth loss in cancer survivors
Knowledge-focused CompletedThis study follows head and neck cancer patients who received radiation therapy to see how many teeth they lose over two years. It also looks at other mouth problems like dry mouth and bone damage. The goal is to better understand and manage these long-term side effects.
Sponsor: Wake Forest University Health Sciences • Aim: Knowledge-focused
Last updated Jul 02, 2026 00:00 UTC
-
Can genes predict liver damage from childhood cancer drugs?
Knowledge-focused CompletedThis study investigates whether certain genetic differences make children with nephroblastoma (kidney cancer) or acute lymphoblastic leukemia (blood cancer) more likely to develop a serious liver condition called hepatic veno-occlusive disease (VOD) during chemotherapy. Researche…
Phase: NA • Sponsor: University Hospital, Angers • Aim: Knowledge-focused
Last updated Jul 01, 2026 00:00 UTC
-
Scientists hunt for hidden genetic causes of rare bleeding disorder
Knowledge-focused CompletedThis study investigates inherited thrombocytopenias, rare conditions where low platelet counts cause bleeding problems. About half of patients have an unknown genetic cause. Researchers aim to identify new disease genes and build a lab-grown bone marrow model to test how well dru…
Sponsor: Fondazione IRCCS Policlinico San Matteo di Pavia • Aim: Knowledge-focused
Last updated Jul 01, 2026 00:00 UTC
-
Blood test could reveal how lung cancer evolves during treatment
Knowledge-focused CompletedThis study investigates whether a simple blood test (liquid biopsy) can track how advanced non-small cell lung cancer changes during immunotherapy or targeted therapy. Researchers will analyze tumor DNA circulating in the blood to see if it can predict treatment response and dete…
Sponsor: Geneplus-Beijing Co. Ltd. • Aim: Knowledge-focused
Last updated Jul 01, 2026 00:00 UTC
-
7-Year checkup: how radiation affects teeth and gums in cancer survivors
Knowledge-focused CompletedThis study follows up with head and neck cancer patients about 7 years after they finished radiation therapy. Researchers will check for cavities, gum disease, tooth loss, bone damage, and saliva flow. The goal is to understand the long-term dental side effects of cancer treatmen…
Sponsor: Wake Forest University Health Sciences • Aim: Knowledge-focused
Last updated Jul 01, 2026 00:00 UTC
-
New obesity drug HRS-7535 put through drug interaction tests
Knowledge-focused CompletedThis Phase 1 study in 40 overweight or obese adults examined how a new drug called HRS-7535 interacts with four common medications: acetaminophen (pain reliever), digoxin (heart medication), rosuvastatin (cholesterol drug), and omeprazole (acid reflux treatment). Participants too…
Phase: PHASE1 • Sponsor: Shandong Suncadia Medicine Co., Ltd. • Aim: Knowledge-focused
Last updated Jul 01, 2026 00:00 UTC
-
Child cancer study tracks brain and behavior over time
Knowledge-focused CompletedThis study looked at how cancer and its treatment affect thinking, memory, emotions, and behavior in children and teens. Researchers collected information from tests and surveys over time to understand these effects. The goal was to learn more, not to test a new treatment.
Sponsor: Children's Oncology Group • Aim: Knowledge-focused
Last updated Jul 01, 2026 00:00 UTC
-
New model aims to perfect antibiotic dosing for sepsis in the ICU
Knowledge-focused CompletedThis study looked at 91 sepsis patients in intensive care to create a computer model that predicts the right dose of the antibiotic piperacillin/tazobactam. Researchers took blood samples at different times to measure drug levels. The goal was to develop a tool that helps doctors…
Sponsor: University Hospital, Rouen • Aim: Knowledge-focused
Last updated Jul 01, 2026 00:00 UTC
-
Nerve mapping during neck surgery could unlock new sleep apnea therapy
Knowledge-focused CompletedThis study looks at a nerve in the neck called the ansa cervicalis, which controls muscles that help keep the airway open. Researchers will measure the nerve's size and shape in 50 adults having neck surgery for head and neck cancer. They will also test how stimulating the nerve …
Phase: NA • Sponsor: Vanderbilt University Medical Center • Aim: Knowledge-focused
Last updated Jul 01, 2026 00:00 UTC
-
Wearable sensors monitor ALS progression in new study
Knowledge-focused CompletedThis study tests whether wearable sensors and digital home tasks can track changes in movement, speech, and falls in people with ALS. About 20 participants will wear neck and wrist sensors and complete speech and handwriting tests over 48 weeks. The goal is to see if these digita…
Sponsor: Milton S. Hershey Medical Center • Aim: Knowledge-focused
Last updated Jul 01, 2026 00:00 UTC
-
Nose drops of pneumonia bacteria could pave way for better vaccines
Knowledge-focused CompletedThis study investigates how a specific strain of pneumococcus bacteria (serotype 3) colonizes the nose of healthy adults. Researchers will give volunteers nose drops containing the bacteria to see what dose leads to colonization and how long the bacteria stay before the immune sy…
Phase: NA • Sponsor: Liverpool School of Tropical Medicine • Aim: Knowledge-focused
Last updated Jul 01, 2026 00:00 UTC
-
AI videos teach denture care to seniors
Knowledge-focused CompletedThis study tests whether watching AI-made educational videos can improve how older adults care for their dentures and feel about their oral health. About 50 people over age 50 who use removable dentures will watch the videos and answer questions. The goal is to see if this simple…
Phase: NA • Sponsor: Sherif Aly Sadek • Aim: Knowledge-focused
Last updated Jul 01, 2026 00:00 UTC
-
Tablet tests could track ALS progression through speech and handwriting
Knowledge-focused CompletedThis study explores whether digital tools on a tablet can measure changes in speech and handwriting in people with motor neuron diseases like ALS. Participants complete a single session of speaking and tracing tasks. Researchers compare results between patients and healthy contro…
Sponsor: Milton S. Hershey Medical Center • Aim: Knowledge-focused
Last updated Jul 01, 2026 00:00 UTC
-
Real-World data reveals how bosutinib fights leukemia outside clinical trials
Knowledge-focused CompletedThis study looks back at medical records from a single hospital in Scotland to see how well the drug bosutinib works and how safe it is for people with chronic myeloid leukemia (CML) in everyday practice. Researchers will track blood cell counts, genetic responses, and side effec…
Sponsor: Pfizer • Aim: Knowledge-focused
Last updated Jul 01, 2026 00:00 UTC
-
10,000 cancer records analyzed to supercharge future treatments
Knowledge-focused CompletedThis study collects and analyzes health records from 10,000 cancer patients across multiple sites. Researchers will use this real-world data to better understand patient populations, improve clinical trial design, and support drug development. No new treatments are tested—the goa…
Sponsor: Tempus AI • Aim: Knowledge-focused
Last updated Jul 01, 2026 00:00 UTC
-
Kidney function may change how antibiotic levornidazole acts in the body
Knowledge-focused CompletedThis study looks at how a single dose of the antibiotic levornidazole is processed by the body in people with moderate or severe kidney impairment compared to healthy volunteers. Researchers will measure drug levels in the blood and urine, and monitor safety. The goal is to under…
Phase: PHASE1 • Sponsor: Yangtze River Pharmaceutical Group Jiangsu Zilong Pharmaceutical Co. Ltd • Aim: Knowledge-focused
Last updated Jul 01, 2026 00:00 UTC
-
Do future doctors know the skin risks of tattoos and piercings?
Knowledge-focused CompletedThis study surveys medical students to understand their attitudes toward tattoos and piercings and measure their awareness of related skin risks, such as infections, allergic reactions, and scarring. Researchers aim to see if students have adequate knowledge and how their views d…
Sponsor: Biruni University • Aim: Knowledge-focused
Last updated Jul 01, 2026 00:00 UTC
-
Lung inflammation may speed heart aging, study investigates
Knowledge-focused CompletedThis study looks at whether chronic lung inflammation from bronchiectasis raises the risk of heart disease and accelerates aging. Researchers will measure heart function, artery stiffness, bone density, muscle mass, and blood markers in 110 adults aged 40 to 80 with confirmed bro…
Sponsor: Centre Hospitalier Intercommunal Creteil • Aim: Knowledge-focused
Last updated Jul 01, 2026 00:00 UTC
-
Which COVID test plan keeps schools safest? study reveals answer for underserved kids
Knowledge-focused CompletedThis study looked at the best way to test for COVID-19 in K-12 schools serving underserved communities. Researchers compared two strategies: testing only people with symptoms versus weekly testing of everyone plus symptom testing. The goal was to see which approach reduced COVID-…
Phase: NA • Sponsor: Washington University School of Medicine • Aim: Knowledge-focused
Last updated Jul 01, 2026 00:00 UTC
-
AI predicts dental numbing success in painful tooth condition
Knowledge-focused CompletedThis study looks at whether computer models can predict if local anesthetic (numbing) will work for people with a painful tooth condition called symptomatic irreversible pulpitis. Researchers analyzed records from 4,390 adult patients to compare three different machine learning a…
Sponsor: Jamia Millia Islamia • Aim: Knowledge-focused
Last updated Jul 01, 2026 00:00 UTC
-
Can a simple activity tracker help cancer survivors move more?
Knowledge-focused CompletedThis study looked at whether using a physical activity screener, along with exercise coaching and self-monitoring, could help breast and colon cancer survivors become more active and spend less time sitting. Twenty survivors who had finished their main cancer treatment at least t…
Phase: NA • Sponsor: Wake Forest University Health Sciences • Aim: Knowledge-focused
Last updated Jul 01, 2026 00:00 UTC
-
Could a winter dip boost your blood? scientists investigate
Knowledge-focused CompletedThis study looks at how regular winter swimming—bathing in cold open water during winter—affects blood cells, blood flow, and stress-fighting enzymes in healthy men. Researchers compare winter swimmers to a control group who never swim in cold water and have a sedentary lifestyle…
Sponsor: University School of Physical Education, Krakow, Poland • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:03 UTC
-
Empty bladder may steady the target in rectal cancer radiation
Knowledge-focused CompletedThis study investigates whether having an empty bladder reduces movement of the mesorectum (tissue around the rectum) during radiotherapy for rectal cancer. About 50 adults with rectal cancer receive planning CT scans and weekly CBCT scans under both empty and full bladder condit…
Phase: NA • Sponsor: Institut Cancerologie de l'Ouest • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:03 UTC
-
Which exercise burns fat better: upper or lower body?
Knowledge-focused CompletedThis study looks at how upper body versus lower body combined strength and endurance training affects two key proteins in overweight and obese men: myostatin, which regulates muscle growth, and hormone-sensitive lipase, which helps break down fat. Thirty-six men were split into t…
Phase: NA • Sponsor: Arya Habibi • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC
-
Could bendy joints be a clue in ADHD?
Knowledge-focused CompletedThis study looks at whether children with ADHD are more likely to have very flexible joints (benign joint hypermobility) and if a certain blood marker differs. Researchers will compare 171 children aged 6 to 12—some with ADHD and some without—using physical exams and blood tests.…
Sponsor: Antalya Training and Research Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC
-
Blood test score may guide ovarian cancer treatment decisions
Knowledge-focused CompletedThis study looks at whether a score called KELIM can predict how well ovarian cancer patients respond to maintenance treatment with PARP inhibitors after initial chemotherapy. Researchers will analyze data from 243 patients who took part in the PAOLA-1 trial. If KELIM proves usef…
Sponsor: ARCAGY/ GINECO GROUP • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC
-
RSV shot uptake under the microscope: how many german babies get protected?
Knowledge-focused CompletedThis study tracks how many infants in Germany receive nirsevimab, a long-acting antibody that helps protect against severe RSV disease. Researchers will survey parents of babies born during three RSV seasons (2024–2027) to measure immunization rates. The goal is to see how well t…
Sponsor: Sanofi Pasteur, a Sanofi Company • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:01 UTC
-
European registry aims to improve care for pancreatic enzyme deficiency
Knowledge-focused CompletedThis study creates a registry of adults with pancreatic exocrine insufficiency (PEI), a condition where the pancreas does not produce enough enzymes to digest food properly. Researchers at eight specialist centers across Europe will track how doctors prescribe pancreatic enzyme r…
Sponsor: Hospital Clinico Universitario de Santiago • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:01 UTC
-
Mapping the hidden germ: pneumococcus in healthy kids
Knowledge-focused CompletedThis study looks at how common pneumococcus bacteria are in the noses and throats of healthy Vietnamese children aged 6 months to 5 years. Researchers will take a simple swab and interview parents about factors like vaccination history, antibiotic use, and living environment. The…
Sponsor: Tam Anh Research Institute • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:01 UTC